Datenquellen im TIB-Portal   Hilfe zur Suche

Unser Tipp: Melden Sie sich an, um alle Funktionen im TIB-Portal optimal nutzen zu können!

Análisis De Costo-Efectividad De Las Vacunas Neumocócicas 13-Valente Y 23-Valente Para Adultos De Alto Riesgo En Colombia (Englisch)

In: VALUE IN HEALTH   ;  16 ,  7  ;  A667  ;  2013
  • ISSN:
    1098-3015
  • Aufsatz (Zeitschrift)  /  Print

Wie erhalte ich diesen Titel?

© Metadata Copyright the British Library Board and other contributors. All rights reserved.

Inhaltsverzeichnis – Band 16, Ausgabe 7

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.

A323
Responsiveness of the EQ-5D in Oncology: A Meta-Analysis
Smith, A. B. / Cocks, K. / Taylor, M. / Parry, D. | 2013
A324
The Multimodel Ensemble Approach to Reducing Structural Uncertainty in Decision Analytical Modelling
Parham, P. E. / Hughes, D. A. | 2013
A325
Bayesian Calibration Method to Estimate Transition Probabilities for a Markov Model Based on a Continuous Outcome Measure: Application in Parkinson’s Disease
Neine, M. / Briquet, B. / Mokdad, C. E. / Vataire, A. L. / Aballea, S. | 2013
A326
A Comparison of Methodologies for Estimating Survival in Patients Treated with Second-generation Tyrosine-kinase Inhibitors (TKIs) for Chronic Myeloid Leukaemia (CML)
Pennington, B. / Batty, A. J. / Clifton-Brown, E. | 2013
A327
Application of Behavioural Economics to the Understanding of Adherence: Does an Individual’s Time Preference Influence Adherence to Medications?
Fargher, E. A. / Morrison, V. / Plumpton, C. O. / Hughes, D. A. | 2013
A328
Quality Criteria for the Development of Implant Registries
Niederländer, C. S. / Wahlster, P. / Kriza, C. / Schaller, S. U. / Kolominsky-Rabas, P. L. | 2013
A329
Mapping the CCQ onto EQ-5D Scores (Im)Possible?
Boland, M. R. / van Boven, J. F. / Rutten-van Mölken, M. P. | 2013
A330
Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment Comparison
Panagiotopoulou, N. / Nethra, S. / Karabis, A. / Ahmad, G. / Burls, A. | 2013
A331
Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil: A Public Perspective Analysis
Ferracini, M. / Nakada, C. P. | 2013
A332
A Cost of a Childbirth with in vitro Fertilization in Poland
Góra, K. / Hermanowski, T. / Wrona, W. | 2013
A333
Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil
Decimoni, T. C. / Sansone, D. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. S. / Fonseca, M. | 2013
A334
Cost Minimization Analysis of the Dienogest Use in Patients with Endometris under Brazilian Public and Private Perspective
Ferracini, M. / Nakada, C. P. | 2013
A335
A Systematic Review of Patient Preferences for Subcutaneous Medications
Ridyard, C. / Dawoud, D. / Hughes, D. A. | 2013
A336
Measurement of Societal Medical Care Preferences with the Same Cost Per Qaly: A Discrete Choice Study
Shiroiwa, T. / Saito, S. / Shimozuma, K. / Kodama, S. / Noto, S. / Fukuda, T. | 2013
A338
Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil
Ferraz, M. B. / Nardi, E. P. | 2013
A339
Health Outcomes of Female Anabolic-Androgenic Steroid Users
Noone, J. / Blanchette, C. M. | 2013
A340
The Geographic Correlation Between Lyme Disease Incidence and Degenerative Neurological Disease Mortality: An Ecological Study
Veley, K. M. / Malka, E. S. | 2013
A341
Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial
Stahmeyer, J. T. / Rossol, S. / Bert, F. / Abdelfattah, A. M. / Mauss, S. / Heyne, R. / John, C. / Pape, S. / Schober, A. / Teuber, G. | 2013
A342
Burden of Varicella in Eastern Europe: A Systematic Review and Critical Analysis
Yang, H. K. / Song, K. M. / Manoff, S. / Liaw, K. L. / Kuter, B. | 2013
A343
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States
Brogan, A. / Talbird, S. E. / Thompson, J. R. / Kim, Y. A. / Olson, J. / Peterson, J. / Piontkowsky, D. / Pietrandoni, G. | 2013
A344
Examining the Relationship Between Country-Level Factors and Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda
Yang, W. / Parisi, M. / Lahue, B. J. / Bishai, D. M. | 2013
A345
Pharmacoeconomic Evaluation of the Fixed-Dose Combination of Abacavir/Lamivudine in the Antiretroviral Therapy of Naïve HIV Infected Patients in Russia
Pyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Andreeva, N. | 2013
A346
Counting the Cost of Meningococcal Disease in France
Faivre, P. / Bénard, S. / Wright, C. / Voisine, J. / Gaudelus, J. | 2013
A347
Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia
Avxentev, N. / Avxentyeva, M. / Platonov, A. / Kolyasnikova, N. / Gridneva, K. / Dolgin, V. / Titkov, A. / Derkach, E. V. | 2013
A348
The Association Between Adherence to Antiretroviral Therapy and Economic Outcomes Among Commercially Insured and Medicaid HIV Patients in the United States
Korsnes, J. S. / Goodwin, B. / Candrilli, S. D. | 2013
A349
Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada
Lachaine, J. / Vachon, M. L. / Lambert-Obry, V. / Beauchemin, C. | 2013
A350
When Treatment Is Mitigated by Adverse Events: The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/Ribavirin
Sullivan, S. / McDermott, C. / Dieterich, D. / Martel-Laferriere, V. / Saab, S. / Gordon, S. | 2013
A351
Cost-Effectiveness Analysis of 3 Candins and Fluconazole in the Treatment of Confirmed Invasive Candidiasis in Adult Non-Neutropaenic Patients in Spain
Grau, S. / Pozo, J. C. / Roma, E. / Salavert, M. / Collados, C. / Egea-García, M. / Mesa, F. J. / Llevat, N. / Barrueta, A. | 2013
A352
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program
Tichopad, A. / Vitova, V. / Roberts, C. S. / Hájek, P. | 2013
A353
A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in Costa Rica
Garita, M. / Solano, A. / Cuesta, G. / Mould, J. | 2013
A355
Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B Vaccination
Cure, S. / Bianic, F. / Nandini Kahol, D. / Davie, A. | 2013
A356
Economic Analysis of Protease Inhibitors in First-Line Haart in Adult Patients with HIV
Avxentyeva, M. / Goryaynov, S. / Rebrova, O. | 2013
A358
Cost-Minimization Analysis of Maraviroc Versus Darunavir Raltegravir and Enfuvirtide for CCR5-Tropic Treatment-Experienced Patients with HIV Infection in Russia
Pyadushkina, E. / Omelyanovsky, V. / Avxentyeva, M. / Rebrova, O. / Goryaynov, S. | 2013
A359
COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND
Kaczor, M. P. / Wójcik, R. / Pawlik, D. / Skrzekowska-Baran, I. / Tronczynski, K. | 2013
A361
Patient Satisfaction with HIV Therapies: Focus on Adherence to Treatment
Murray, M. / Dang, N. / Swinburn, P. / Gallop, K. / Lloyd, A. | 2013
A362
Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)
Baran, R. W. / Anderson, R. T. / Dietz, B. / Gooch, K. | 2013
A364
United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications
Hogue, S. / Brogan, A. / Goodwin, B. | 2013
A365
Clinical Guidelines Evidence as a Criterion for Changes in the Legislation Combating Tuberculosis
Stepanenko, A. / Lishchyshyna, O. / Melnyk, Y. | 2013
A366
RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)
Paes, B. A. / Li, A. / Mitchell, I. / Lanctot, K. L. | 2013
A367
Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico
Gryzbowski, E. / Peniche-Otero, G. / Herrera-Rojas, J. / Bolaños-Cornejo, D. / Huicochea-Bartelt, J. L. / Muciño-Ortega, E. | 2013
A368
The Influence of Improved Adherence and Persistence in Chronic Obstructive Pulmonary Disease (COPD) Costs: Systematic Review of the Literature
Pérez, M. / Dominguez, J. / Armengol, S. / Paz, S. / Lizán, L. | 2013
A369
Impact of Chronic Pain on Health Care Costs in Chronic Obstructive Pulmonary Disease as Compared to Other Chronic Diseases
Mapel, D. / Roberts, M. / Von Worley, A. | 2013
A370
Predicting Health Care Costs in Asthma Using the EQ-5D Index Score
Gu, N. Y. / Raisch, D. W. / Wu, J. / Gai, Y. / Hay, J. W. | 2013
A371
Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients from a Swedish Societal Perspective
Costa-Scharplatz, M. / Tambour, M. / Henriksson, F. / Ställberg, B. | 2013
A372
Empirical Therapy for Respiratory Tract Infections in an Era of Increasing Antimicrobial Resistance: A Decision and Cost Analysis
Babela, R. | 2013
A373
Factors Related to Adherence After a Multifactorial Intervention to Improve It in Patients with Chronic Obstructive Pulmonary Disease (COPD). Icepoc Study
Leiva-Fernandez, F. / Leiva-Fernandez, J. / Prados-Torres, D. / García-Ruiz, A. J. / Barnestein-Fonseca, P. | 2013
A374
Patient-Reported Outcome (PRO) Claims in Products Approved for Chronic Obstructive Pulmonary Diseases (COPD) in Europe and the United States
Caron, M. / Perrier, L. L. / Acquadro, C. | 2013
A375
The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-Forms
Sherbourne, C. / Stucky, B. / Edelen, M. O. / Eberhart, N. / Lara, M. | 2013
A376
Patterns in Asthma Medicationtreatment in the United States
Li, Y. / Suh, K. / Chen, W. / Wei, Z. / Higuchi, K. | 2013
A377
Clinical Effectiveness Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions
Walczak, J. / Lipińska, M. / Jarosz, J. / Moczyński, W. / Ślązak, B. / Laczewski, T. | 2013
A378
Budget Impact Analysis of Deferasirox in the Treatment of Non Transfusion Dependent Thalassemia in Greece
Masoura, P. / Murphy, D. R. / Chatzikou, M. / Alexopoulos, S. T. / Magestro, M. | 2013
A379
Pharmacoeconomic Evaluation of Intravenous Ferric Carboxymaltose and Iron Sucrose in Correction of Preoperative Anaemia in Patients Undergoing Major Elective Surgery
Gorokhova, S. G. / Ryazhenov, V. V. / Emchenko, I. V. | 2013
A380
Haemophilia A: Annual Cost Comparison Between FL-rFVIII and BDD-rFVIII in France: We Should Compare the Cost Per Patient Instead of the Price Per Unit
Haarmann, H. / Epstein, J. / Grumel, O. | 2013
A381
A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney Disease
Rizzo, M. / Iheanacho, I. / van Nooten, F. E. / Goldsmith, D. | 2013
A382
Cost-Consequence Analysis of a Treatment Strategy Including Ponatinib Compared to a Treatment Strategy Including Only the 2nd Generation Tyrosine Kinase Inhibitors (2g TKIs), Dasatinib or Nilotinib, in Resistant Patients with Philadelphia Chromosome-Positive (Ph+) Leukemia, in Italy
Chiroli, S. / Furneri, G. / Pane, F. | 2013
A383
The Potential of a Reduction in the Risk of Opioid-Related Fractures to Drive the Cost-Effectivness of an Analgesic
Cawson, M. / Knight, C. / Hirst, M. / Dunlop, W. | 2013
A384
Cost-Effectiveness of Plerixafor (PXF) for Stem Cell Mobilization in Lymphoma (NHL/HL) and Multiple Myeloma (MM) Patients in Poland
Kaczor, M. P. / Wójcik, R. / Pawlik, D. / Glasek, M. / Pieczonka, A. / Lis, J. | 2013
A385
Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy
Zaniolo, O. / Povero, M. / Gandini, G. / Aprili, G. / Eandi, M. | 2013
A386
The Use of Preference Based Measures in Haemophilia: Is the Current Evidence Base Useful for Evidence Based Decision Making?
Tolley, K. / Miners, A. / Brazier, J. / Pericleous, L. M. / Sharma, T. / Petersen, J. / Lonergan, T. | 2013
A387
The Impact of Increasing Pain Severity on Impairment of Regular Daily Activities
Poole, C. D. / Chambers, C. / Odeyemi, I. / Currie, C. | 2013
A388
Likelihood of Use and Perception Towards Biosimilars in Rheumatoid Arthritis Arena: Survey of Rheumatologists in European Union, Brazil, Japan and China
Narayanan, S. / Liu, L. | 2013
A389
Appetite Suppressants: A Drug Utilisation Study
Truter, I. | 2013
A390
Cost-Minimization of Mabthera Intravenous Versus Subcutaneous Administration
Bax, P. / Postma, M. J. | 2013
A392
Evaluation of the Burden of Illness of Colorectal Cancer Among Veteran Patients in the United States
Wang, L. / Xie, L. / Li, L. / Wang, Y. / Kariburyo, M. F. / Baser, O. | 2013
A393
An Indirect Treatment Comparison of the Efficacy of Everolimus (Afinitor®) and Fulvestrant for the Treatment of Hormone Receptor Positive (HR+) HER2 Negative (HER2–) Advanced or Metastatic Breast Cancer
Chandiwana, D. / Vieira, J. / Granville, J. / McCool, R. / Fleetwood, K. | 2013
A394
A Mixed Treatment Comparison (MTC) to Compare Progression Free Survival (PFS) Associated with Different Chemotherapy Regimens for Platinum-Sensitive or Partially Platinum-Sensitive Recurrent Advanced Ovarian Cancer
Edwards, S. J. / Barton, S. / Thurgar, E. / Wakefield, V. / Karner, C. / Trevor, N. | 2013
A395
Second-Line Treatment of Metastatic Colorectal Cancer (mCRC): A Systematic Literature Review (SLR) and Feasibility Assessment of Conducting Indirect Treatment Comparison (ITC) Analysis
Xu, Y. / Martin, A. L. / Ross, S. / Knopf, K. B. / Strand, L. / Iqbal, S. U. / Joulain, F. / Jasso Mosqueda, J. G. / Fahrbach, K. | 2013
A396
Off-Label Trastuzumab Usage in Breast Cancer Patient in Turkey
Kockaya, G. / Tanyeri, P. / Buyukokuroglu, M. E. / Yenilmez, F. B. / Durmus, D. / Vural, I. M. / Akbulat, A. / Artiran, G. / Gursoz, H. / Kerman, S. | 2013
A397
Aflibercept + FOLFIRI (AF) Versus. Placebo + FOLFIRI (PF) in Metastatic Colorectal Cancer (mCRC): Mean Overall Survival (OS) in a “Better Responders� Patient Population of the Velour Trial
Joulain, F. / Naoshy, S. / Chau, I. / Iqbal, S. U. / Bridgewater, J. | 2013
A398
Economic Impact of Denosumab for Skeletal Related Event Prevention in Patients with Prostate Cancer and Bone Metastasis from a United State Managed Care Organization Perspective
Arellano, J. / Cristino, J. / Chen, K. | 2013
A399
Breast Cancer Screening Program in the Basque Country: Costs and Health Benefits Assessment Through Discrete Event Simulation
Arrospide, A. / Mar, J. / Comas, M. / Rue, M. / Larrañaga, N. / Acaiturri, T. / Sarriugarte, G. | 2013
A400
Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia
Walzer, S. / Tournier, C. / Marino, J. P. / Mueller, E. / Duong, M. | 2013
A401
Cost of Adverse Events During Treatment with Everolimus Plus Exemestane or Single-Agent Chemotherapy in Patients with Advanced Breast Cancer
Campone, M. / Yang, H. / Faust, E. / Kageleiry, A. / Signorovitch, J. / Zhang, J. / Gao, H. | 2013
A402
Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health Disparities
Walton, S. / Johnson, T. J. / Li, C. C. / Joyce, B. | 2013
A403
The Humanistic and Economic Burden of Venous Thromboembolism in Cancer Patients: A Systematic Review
Kourlaba, G. / Relakis, J. / Kontodimas, S. / Holm, M. V. / Maniadakis, N. | 2013
A404
Estimating the Cost of HPV-Related Diseases in Turkey: A Delphi Approach
Bakir, M. / Ayhan, A. / Arvas, M. / Kose, M. F. / Gungor, M. / Ortac, F. / Ozgul, N. / Yuce, K. / Ergun, T. / Gungor, E. | 2013
A405
Economic Burden of Toxicities Associated with Advanced Melanoma Treatments in France, Italy, the Netherlands, and Spain
Bilir, S. P. / Zhao, Z. / Wehler, E. A. / Munakata, J. / Barber, B. | 2013
A407
Estimation of the Epidemiological and Economic Impact of the Quadrivalent HPV Vaccination in Girls and Boys in Spain
Bosch, X. / Cortés Bordoy, J. / Gil de Miguel, A. / López Belmonte, J. L. / Bresse, X. / Serip, S. / Nieves, D. | 2013
A408
Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer
Marteau, F. / Kornowski, A. / Bennison, C. / Tempest, M. J. / Mariappan, P. / Witjes, J. A. | 2013
A409
Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany
van Beurden-Tan, C. / Rosiñol, L. / Diels, J. / Wirth, D. / Chirita, O. / Lahuerta, J. J. / Gaugris, S. / Marsh, S. / San Miguel, J. / Spencer, M. | 2013
A410
Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma
Rochau, U. / Jahn, B. / Qerimi, V. / Kluibenschaedl, M. / Kurzthaler, C. / Conrads-Frank, A. / Willenbacher, W. / Gastl, G. / Siebert, U. | 2013
A411
A Cost-Effectiveness Analyses of Using Sunitinib (SU) in First Line of Metastatic Renal Cancer in Romanian Jurisdiction
Berghea, F. / Skoupa, J. / Ciuleanu, T. / Miron, L. / Stanculeanu, D. L. / Jinga, D. / Dediu, M. / Mateescu, D. N. / Hájek, P. / Bradatan, B. | 2013
A413
Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated with Highly and Moderately Emetogenic Cancer Chemotherapy in Russia
Krysanov, I. / Krysanova, V. | 2013
A414
Cost-Effectiveness of First-Line Treatment of Advanced Metastatic Non Small Cell Lung Cancer- A Systematic Review of Economic Models
Eijgelshoven, I. / Verduyn, S. C. / Bhatti, T. / Bexelius, C. / Jansen, J. P. | 2013
A415
Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan
Shibahara, H. / Shiroiwa, T. / Nakamura, K. / Shimozuma, K. | 2013
A416
Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in Spain
Crespo, C. / Seguí, M. / Cortés, J. / Lluch, A. / Brosa, M. / Becerra, V. / Chiavenna, S. M. / Gracia, A. | 2013
A417
Economic Activity of Cancer Survivors in Poland
Macioch, T. / Hermanowski, T. R. | 2013
A418
Persistence in Patients with Breast Cancer Treated with Tamoxifen or Aromatase Inhibitors- Analysis Based on Oncology Analyzer Database
Schmidt, N. / Haas, G. / Mergenthaler, U. / Kostev, K. / Hadji, P. | 2013
A420
Systematic Review of Patient Reported Outcomes in Chronic Myeloid Leukemia
Aggarwal, S. / Segal, J. / Topaloglu, H. | 2013
A421
Influence of Anxiety and Depression on 1-Year Health Related Quality of Life in Colorectal Cancer Patients
Escobar, A. / Billbao, A. / Trancho, Z. / Quintana, J. / Sarasqueta, C. / Baré, M. | 2013
A422
HR-QOL Data in the Amnog Early Benefit Assessment: Industry and IQWIG/GBA Perspective
Obradovic, M. / Radicek, S. / Rauland, M. | 2013
A424
Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of Life
Moïse, P. / Sweeney, N. / Lie, X. | 2013
A425
A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Lines
van Rooijen, E. M. / Uyl-de Groot, C. A. / Punt, C. / Koopman, M. / Coupe, V. M. | 2013
A427
A Novel Algorithm Using Claims Data to Identify Patients with Castration-Resistant Prostate Cancer (CRPC)
Gorritz, M. / Thompson, S. F. / Lee, Y. C. / Stern, L. / Penson, D. F. | 2013
A428
Impact of Recommended Pharmaceuticals on Cancer Mortality: Analysis of Real-Life Data
Wilson, T. / Hamerslag, L. | 2013
A429
Economical Losses Due to Disablementparents Carring for Children with Oncohematological Diseases
Ganieva, D. / Zhukovskaya, E. / Spichak, I. | 2013
A432
A Bayesian Multiple Treatment Comparison of Duloxetine, Pregabalin, Gabapentin, Amitriptyline, and Their Combinations for Painful Peripheral Neuropathy Based on Pain Reduction Reported in Clinical Trails
Chinthammit, C. / Malone, D. | 2013
A433
The Presence of Metabolic and Other Risk Factors in Adrenal Insufficiency Patients Compared to an Unmatched Background Population from the Same Region in the United Kingdom
Teneishvili, M. / Marelli, C. / Lee, D. | 2013
A434
Early Life Determinants of Metabolic Syndrome and Diabetes Mellitus in South Asian Population Living in Europe: A Systematic Review
Callejo, D. / Díaz-Cuervo, H. / Cuervo, J. / Rebollo, P. / Hussain, A. / Hitman, G. A. | 2013
A436
Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin
Foos, V. / Grant, D. / Palmer, J. L. / Varol, N. / Curtis, B. / Boye, K. S. / McEwan, P. | 2013
A437
First Russian Type 2 Diabetes Mellitus Simulation Model with Discrete Events Modeling. Health-Economic Analysis
Kolbin, A. / Kurylev, A. / Balykina, Y. / Proskurin, M. | 2013
A439
Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan Children
Roze, S. / Demessinov, A. / Zeityn, M. / Toktarova, N. / Abduakhassova, G. / Sissemaliev, R. / Karamalis, M. / Dunne, N. / Muratalina, A. / Klots, M. | 2013
A440
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting
Willis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Girod, I. / Neslusan, C. | 2013
A441
Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting
Girod, I. / Willis, M. / Johansen, P. / Schroeder, M. / Thompson, G. / Neslusan, C. | 2013
A442
The Cost-Utility of Insulin Degludec Compared with Current Standard of Care in the Management of Type One and Type Two Diabetes Mellitus in Belgium
Jugrin, A. V. / Lamotte, M. / Malfait, M. / Vandebrouck, T. | 2013
A443
Review of Cost of Diabetes Complications in Four European Countries
Beaudet, A. / Grabbi, E. / Maurel, F. / Ramos, M. / Lebioda, A. | 2013
A444
Do Fixed-Dose Combinations Improve Antidiabetic Treatment Compliance? A Study Based on French IMS Lifelink Disease Analyzer Database
Grandfils, N. / Le Jeunne, P. / Maillard, C. / Solomiac, A. / Besson, A. | 2013
A445
Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in Poland
Sobol, E. / Macioch, T. / Krakowiecki, A. / Mrozikiewicz-Rakowska, B. / Mienicka, A. / Mlynarczuk, M. / Kasprowicz, M. / Paweska, J. / Karnafel, W. / Hermanowski, T. R. | 2013
A446
Assessing Quality of Life in Adult Growth Hormone Deficiency: Further Development of the QoL-AGHDA
Graham, J. E. / McKenna, S. / Wilburn, J. / Twiss, J. | 2013
A448
Impact of Nocturnal and Daytime Non-Severe Hypoglycaemic Events on People with Diabetes in South Africa
Snyman, J. / Todorova, L. | 2013
A449
The Impact of Memory Problems on Diabetes Treatment in Germany
Brod, M. / Kongso, J. / Bushnell, D. M. | 2013
A451
Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care System
Kececioglu, S. / Ulus, P. / Cukadar, F. / Ozkan, M. / Urganci, B. | 2013
A453
How Co-Payment Mechanism Has Changed Patients’ Perception Towards Otc-Type Products?
Deger, C. C. / Tuna, E. / Ozdemir, Z. / Ozel, M. O. / Parali, E. / Sumer, F. / Yilmaz, Z. S. | 2013
A455
Characterising Preliminary Profile Paramaters for FDA Breakthrough Therapy Candidates
Labban, M. / Izmirlieva, M. / Ando, G. | 2013
A456
2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS
Dehnen, J. / Schmoeller, M. | 2013
A457
Pricing of “Follow-On� Drugs and Competition Within Pharmaceutical Classes: Evidence from Germany 1993-2008
Mueller, M. T. / Frenzel, A. | 2013
A458
Constructing an Index of International Pharmaceutical Prices. A Comparison of Pharmaceutical Prices in 56 Countries
Davey, P. | 2013
A459
EU Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions
Hogue, S. / Hollis, K. / McLeod, L. / Brogan, A. / Heyes, A. E. | 2013
A460
How Does Prescription of Generic Drugs Spread Out?: Data Mining and Visualization by Using Prescription Data Form Acute Care Hospitals Nationwide
Shimizu, S. / Ishikawa, K. B. / Ikeda, S. / Fushimi, K. | 2013
A461
A Systematic Evaluation of Drug-Drug Interactions in Prescriptions; Facts and Comparisons
Ahmad, M. / Arshad, W. / Usman Minhas, M. | 2013
A462
Current Status and Evidence of Effects of E-Prescribing Implementation in United Kingdom, Italy, Germany, Denmark, Poland and United States
Hermanowski, T. R. / Kowalczyk, M. / Szafraniec-Burylo, S. I. / Krancberg, A. N. / Pashos, C. L. | 2013
A463
Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary
Cs. Horváth, Z. / Molics, B. / �goston, I. / Sebestyén, A. / Boncz, I. | 2013
A464
Variability in Publically-Prescribed Drug Costs: The Role of Region, Age and Gender
O Céilleachair, A. J. / Woods, N. / O’Sullivan, K. / Kenneally, M. | 2013
A465
Cost-Effectiveness of an Interface Geriatric Intervention: Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)
Tanajewski, L. / Franklin, M. / Gkountouras, G. / Berdunov, V. / Edmans, J. / Conroy, S. / Bradshaw, L. / Gladman, J. / Elliott, R. A. | 2013
A466
Pharmaceutical Expenditure, Clinical Outcomes and Expenditures on Other Health Services
Siskou, O. / Galanis, P. / Tsavalias, K. / Kalogeropoulou, M. / Kaitelidou, D. / Pasaloglou, S. / Schneider, M. / Liaropoulos, L. | 2013
A468
Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia
Medic, G. / Baltezarevic, D. / Novakovic, T. | 2013
A469
Acceptability of Indirect Evidence to Support Drug Reimbursement in Australia
O’Leary, B. A. / McKenna, S. J. / Cheng, Y. Y. / McElroy, H. J. | 2013
A471
Investigating Safety-Appraoch in Saudi Arabia Ministry of Health Hospitals
Alkelya, M. A. / Haleem, R. M. | 2013
A472
Confidential Patient Access Schemes in the United Kingdom – Do They Affect Prices in Other Markets?
Nijhuis, T. / Haigh, J. / Van Engen, A. | 2013
A473
A Systematic Comparison of Market Access and Reimbursement Pathways for Diagnostic Tests in Germany, United Kingdom and the United States
Walzer, S. / Gartemann, J. | 2013
A474
Pricing and Reimbursment of Pharmaceuticals in Iran
Moradi, M. | 2013
A475
A Comparison of Coverage and Reimbursement Decisions in Germany (AMNOG) and Scotland (SMC)
Charokopou, M. / Heeg, B. / Schoeman, O. / Mueller, S. / Tempest, M. J. / Schlagmüller, S. C. / Wilke, T. | 2013
A476
Point of Care Tests: The Long and Winding Road to Reimbursement
Hogue, S. / Brogan, A. / Heyes, A. | 2013
A478
Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in Turkey
Kockaya, G. / Daylan Kockaya, P. / Ergin, G. | 2013
A479
Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta Consensus
Cicchetti, A. / Gasbarrini, A. / Ruggeri, M. / Sacchini, D. / Lanati, E. P. | 2013
A480
Key Drivers of Pbac Decisions for the Reimbursement of Orphan Drugs on the Life Saving Drugs Program
Maguire, B. / Tilden, D. | 2013
A481
Analysis of Transparency Amongst International Health Technology Assessment Organizations
Jebrail, F. / Duong, M. / Shum, D. | 2013
A482
Which Should Be the Correct NMA to Be Used? A Review of HTA Recommendations
Solozabal, M. / Roset, M. / Rojas-Farreras, S. / González-Rojas, N. / Gil, A. | 2013
A483
Number of Submissions Needed to Reach a Positive Reimbursement Decision from SMC, CADTH, and PBAC
Jaksa, A. / Ho, Y. S. / Daniel, K. | 2013
A484
Relevance of Indirect Comparisons in the German Early Benefit Assessment (AMNOG)
Lebioda, A. / Gasche, D. / Dippel, F. W. / Plantör, S. | 2013
A485
Systematic Review on Use of Economic Evidence by Clinical Guidelines
Aggarwal, S. / McGrane, M. / Topaloglu, H. | 2013
A486
Guidance for Partnership Working Between CatSalut and the Pharmaceutical Industry
Gilabert, A. / Espinosa, C. / Mora, R. / Santos, J. | 2013
A487
Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?
Kornfeld, A. / Schroeder, M. / Toumi, M. | 2013
A489
The Framework for Health Economic Modeling and Multi-Criteria Decision Analysis (MCDA) on the Example of the Mobile Stroke Unit (MSU)
Wahlster, P. / Niederländer, C. S. / Kriza, C. / Kolominsky-Rabas, P. L. | 2013
A490
How Do Oncology Drug Prices Vary Across EU5, the United States, and Bric Markets?
Patel, P. / Donze, B. / Zaganelli, D. | 2013
A491
Review of Economic Principles of Branded “Me-Too� Drugs Market
Hren, R. | 2013
A492
Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and Spain
Wasserman, M. / Jones, C. / Roberts, G. / Latif, F. | 2013
A494
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy
La Torre, G. / Miele, L. / Mannocci, A. / Saulle, R. / Giraldi, G. / Unim, B. / Ursillo, P. / Semyonov, L. / Colamesta, V. / Melcarne, R. | 2013
A495
Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)
Murray-Thomas, T. / Dedman, D. / Canavan, C. / West, J. / Card, T. | 2013
A496
An Economic Evaluation Comparing ePTFE Covered Stent-Grafts Configured for Tips with Bare Metal Stents in Procedures for the Treatment of Portal Hypertension Complications
Burke, M. / Hacking, N. / Wright, M. / Iqbal, K. / Craig, J. | 2013
A497
Crohn’s Disease: An Economic Assessment of Biological Drugs in Italy
Cicchetti, A. / Gasbarrini, A. / Ruggeri, M. | 2013
A499
Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s Disease
Wilburn, J. / McKenna, S. / Twiss, J. / Kemp, K. / Campbell, S. | 2013
A500
Systematic Literature Review in Moderate to Severe Ulcerative Colitis
Huisman, E. / Medic, G. / Eijgelshoven, I. / Weijers, L. / Karabis, A. | 2013
A501
Indirect Comparison of the Effect of Biologics in Patients with Psoriasis; A Meta-Analysis of Randomized, Double Blind Clinical Trials in Bayesian Framework
Brodszky, V. / Mo, M. / Gulacsi, L. / Baji, P. / Balogh, O. / Péntek, M. | 2013
A502
Children with Atopic Dermatitis: Monitoring a French Cohort Over a Nine-Year Period
Taieb, C. | 2013
A503
Spectacle Independence and Vision-Related Quality of Life in Cataract Surgery Patients Following Implantation of a Multifocal Intraocular Lens
Samiian, A. / Carones, F. | 2013
A504
Costs of Best Supportive Care in the Treatment of Moderate-To-Severe Psoriasis in the United States
Tencer, T. / Li, S. / Zhang, F. | 2013
A505
Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in the United Kingdom
Betts, K. A. / Sundaram, M. / Mughal, F. / Yan, S. Y. / Signorovitch, J. / Wang, K. / Wu, E. Q. | 2013
A506
The Cost-Effectiveness of Bimatoprost 0.03%/Timolol 0.05% Preservative-Free Fixed Combination Compared with Dorzolamide/Timolol Preservative-Free Fixed Combination and 2-Bottle Unfixed Combinations for the Treatment of Primary Open-Angle Glaucoma in the United Kingdom
Hirst, A. / Almond, C. / Brereton, N. J. / Shergill, S. / Wong, W. | 2013
A507
Cost-Effectiveness of Sequences of Biologic Treatments for Moderate-To-Severe Psoriasis in Finland
Asseburg, C. / Valgardsson, S. / Soini, E. J. | 2013
A508
The Burden Imposed by Atopic Dermatitis on Families: Creation of a Specific Questionnaire
Taieb, C. / Branchoux, S. | 2013
A509
Quality of Life of Patients Suffering from Exudative Age-Related Macular Degeneration and Treated by Intravitreal Injections and Its Predictors: The Equade Study
Leveziel, N. / Joubert, M. / Hermans, M. / Moser, E. / Le Picard, S. / Maurel, F. | 2013
A511
Adherence by Spanish Retinologists to the Guidance for the Management of Patients with Wet Age-Related Macular Degeneration
Colomé, A. / Balaña, M. / Ruiz Moreno, J. M. / Roura, M. | 2013
A512
High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting: Treatment Patterns and Outcomes
Degli Esposti, L. / Sangiorgi, D. / Buda, S. | 2013
A513
Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant?
Ibrahim, N. / Norris, L. / O’Toole, S. / Gleeson, N. | 2013
A514
Indirect Comparisons of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: A Systematic Literature Review
Claflin, A. B. / Liu, X. / Phatak, H. | 2013
A515
Anticoagulant Use in Hospitalized Patients with Acute Venous Thromboembolism in the United States
Liu, X. / Xie, L. / Phatak, H. / Mardekian, J. / Tan, W. / Baser, O. / Schneider, R. F. / Ramacciotti, E. | 2013
A518
A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular Disease
Corbo, M. / Beccagutti, G. / Manda, B. | 2013
A519
Pharmacoeconomic Benefits of Citicoline in the Treatment of Acute Ischemic Stroke in Russia
Ryazhenov, V. V. / Gorokhova, S. G. | 2013
A520
The Burden of Resistant Hypertension in 5 European Countries
Sapoval, M. / Hale, B. C. / Armstrong, S. / Da Deppo, L. / Hertz, D. / Briggs, A. | 2013
A521
Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)
Berger, A. / LaPensee, K. / Oster, G. | 2013
A523
Reanalyzing Using Bayesian Methods and Updated Data the Cost-Efectiveness Assumptions of Carotid Artery Stenosis Treatments
Smolen, H. J. | 2013
A524
Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in Greece
Athanasakis, K. / Arzoumanidou, D. / Karampli, E. / Armelidou, E. / Giovas, P. / Petrikkou, E. / Kyriopoulos, J. | 2013
A525
Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy
Capri, S. / Veneziano, M. / Ricciardi, W. G. / D’Ausilio, A. / Pedone, M. P. / Bianchi, C. | 2013
A526
The Cost-Effectiveness of Dabigatran and the Opportunity Cost of Delayed Subsidised Access in Australia
Tilden, D. / Germanos, P. / Gordon, J. / Tocchini, L. | 2013
A527
The Cost-Utility of Catheter-Based Renal Denervation as Compared to Current Standard of Care for Resistant Hypertension in Belgium
Jugrin, A. V. / Caekelbergh, K. / Vanacker, J. / Vancauwenberghe, L. / Lamotte, M. | 2013
A528
Cost-Effectiveness Analysis of Ivabradine in Chronic Heart Failure in the Polish Setting
Borowiec, L. / Faluta, T. / Filipiak, K. J. / Niewada, M. / Wrona, W. | 2013
A529
Economic Evaluation of Apixaban for the Prevention of Stroke in Atrial Fibrillation in the Netherlands
Stevanovic, J. / Pompen, M. / Le, H. H. / Rozenbaum, M. H. / Postma, M. J. | 2013
A530
Cost-Utility Analysis of Coronary Artery Calcium Score to Guide Statin Therapy in Patients with Elevated C-Reactive Protein and Low LDL Cholesterol Levels
Silva Miguel, L. / Ferreira, A. M. | 2013
A531
Real World Resource Use Associated with Transcatheter Aortic Valve Implantation and Conventional Aortic Valve Replacement Surgery
Awad, W. / Mathur, A. / Baldock, L. / Oliver, S. / Kennon, S. | 2013
A532
Effects of the Occurrence of a First Cardiovascular Event on Statin Adherence in Type 2 Diabetes: A Matched Cohort Design
de Vries, F. M. / Denig, P. / Vegter, S. / Bos, H. J. / Postma, M. J. / Hak, E. | 2013
A533
The Relation Between the Modified Rankin Scale (mRS) Scores and Utility Weights: Results from a Survey Among Community Dwelling Long Term Stroke Survivors
Greenberg, D. / Ginsberg, G. / Ziv, A. / Litmanovitch-Goldstein, D. / Tanne, D. / Chodick, G. / Balicer, R. D. / Dankner, R. | 2013
A534
A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive Patients
Hong, J. M. / Kim, E. G. / Min, K. / Min, J. / Shin, K. / Yang, B. M. | 2013
A535
Coronary Artery Disease, Diabetes, and Health-Related Quality of Life: Findings of a Cohort Study from India
Shah, B. S. / Deshpande, S. S. | 2013
A536
Adherence to Warfarin Treatment in Brazil: Systematic Review of the Literature
Feijo, L. F. / Clark, O. A. / Monteiro, R. C. / Fujii, R. K. / Donato, B. M. / Bernardino, G. D. / Barbieri, D. E. / Mould, J. / Manfrin, D. F. | 2013
A537
Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-Savings
Costa, S. / Guerreiro, J. P. / Baptista, A. / Teixeira, I. / Torre, C. | 2013
A538
Analysis of Re-Hospitalisations for Stroke and Transient Ischemia Recurrence and Associated Costs in the Burgundy Region in France
Marty, R. / Jouaneton, B. / Giroud, M. / Mougin, P. / Roze, S. | 2013
A539
The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for Germany
Mennicken, R. / Hentschker, C. | 2013
A540
Divergence of HTA Decisions Across Countries: Case Analysis of Ivabradine
Thivolet, M. / Rémuzat, C. / Kornfeld, A. / Toumi, M. | 2013
A541
Results from the “Autor� Study, a European Observational Study in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
Haynes, V. / Lopez-Romero, P. / Anand, H. | 2013
A542
Comparative Efficacy and Metabolic Side Effects of Lurasidone for the Management of Acute Schizophrenia: A Systematic Literature Review and Mixed Treatment Comparison with First and Second Generation Antipsychotics
Guelfucci, F. / Watt, M. / Vimont, A. / Roïz, J. / Cadi-Soussi, N. | 2013
A543
Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study
Saragoussi, D. / Haro, J. M. / Boulenger, J. P. / Jönsson, B. / Knapp, M. / Caillou, H. / Chalem, Y. / Milea, D. / François, C. | 2013
A544
Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Post-Traumatic Stress Disorder in the United States
Xie, L. / Dysinger, A. H. / Wang, L. / Du, J. / Huang, A. / Baser, O. | 2013
A545
Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries: THE Results of the Literature Review
Walczak, J. / Augustyńska, J. / Miernik, K. / Stelmachowski, J. / Pieniazek, I. / Obrzut, G. / Pogroszewska, A. / Szkultecka-Debek, M. / Paulic, G. / Maric, D. | 2013
A546
Register Based Analysis of Treatment Costs of Second Generation Antipsychotics in Schizophrenia
Borsi, A. / Takacs, P. / Feher, L. | 2013
A547
How Should an Antidepressant with Reduced Risk of Sexual Dysfunction Be Positioned in Treatment Strategies for Patients with Major Depressive Disorder?
Massetti, M. / Vataire, A. L. / Cristeau, O. / Toumi, M. / Aballea, S. | 2013
A549
Comparison of Health Care Resource Utilization and Costs Among Children and Adolescents with Attention Deficit Hyperactivity Disorder in Germany Who Initiated Treatment with Atomoxetine or Long-Acting Methylphenidate
Curtice, T. G. / Greven, P. / Yeaw, J. / Sikirica, V. / Chen, Y. J. / Setyawan, J. / Makin, C. | 2013
A550
Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in India
Negi, H. / Raval, A. / Malay, M. | 2013
A551
Developing an Individualized E-Health Decision Support System for Dementia Treatment and Care: The FP7 EU-Project E-Health Monitor (EHM)
Schaller, S. U. / Kriza, C. / Niederländer, C. / Wahlster, P. / Kolominsky-Rabas, P. L. | 2013
A552
Patients’ Characteristics and Patterns of Use of Depot Antipsychotics in Swedish Patients with Schizophrenia
Depont, F. / Rouleau, A. / Osby, U. / Sobocki, P. / Milea, D. | 2013
A553
Impact of Autism Spectrum Disorders on the Family – A National Perspective
Vohra, R. / Madhavan, S. / Sambamoorthi, U. | 2013
A554
The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis Patients
Doddapaneni, S. / Khera, K. / Prabhu, V. A. / Nagappa, A. N. / Rau, N. R. | 2013
A556
Comparative Effectiveness of Active Versus Sham Acupuncture Versus Usual Care in the Management of Chronic, Non-Cancer Pain in Primary Care
Saramago, P. / Weatherly, H. / Manca, A. / Sculpher, M. J. / MacPherson, H. | 2013
A558
Potential Economic Impact of Using Sugammadex for the Routine Reversal of Neuromuscular Blockade in Russian Health Care Setting
Derkach, E. V. / Avxentyeva, M. V. / Omelyanovsky, V. V. | 2013
A560
Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected Studies
Wladysiuk, M. / Bebrysz, M. / Rutkowski, J. / Haldas, M. / Fedyna, M. | 2013
A561
Biological Treatment Patterns and Associated Costs for Patients with Rheumatoid Arthritis in Taiwan
Wu, C. H. / Chuang, P. Y. / Tang, C. H. | 2013
A562
Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy
Ryazhenov, V. V. / Emchenko, I. V. | 2013
A564
Current and Future Strategy for Osteoporosis Screening and Diagnostics: Cost-Effectiveness of Frax with or without Pulse-Echo Ultrasound Measurement of Bone Mineral Density and DXA on Demand
Asseburg, C. / Riekkinen, O. / Karjalainen, J. K. / Kröger, H. / Soini, E. J. | 2013
A566
Resource Use Due to Disability in Polish Rheumatoid Arthritis Patients: Significant Increase of Transportation Needs and Home Visits
Szafraniec-Burylo, S. I. / Orlewska, E. / Rupinski, R. / Filipowicz-Sosnowska, A. | 2013
A567
Persistence & Compliance to Treatment for Osteoporosis in Postmenopausal Women in Hungary: A Retrospective Cohort Study
Lakatos, P. / Tóth, E. / Cina, Z. / Lang, Z. / Psachoulia, E. / Intorcia, M. | 2013
A568
Are Patients’ Preferences for Osteoporosis Drug Treatment Transferable Between Countries? Results from a Discrete-Choice Experiment Conducted in Two European Countries
Hiligsmann, M. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Goemaere, S. / McGowan, B. / Reginster, J. Y. / Watson, V. / Boonen, A. | 2013
A569
Health Outcomes and Economic Burden of Post-Knee Replacement Surgery in Osteoarthritis Patients: Comparison with Matched Controls
Pignot, M. / DiBonaventura, M. | 2013
A570
Factors Associated with Absenteeism in Rheumatoid Arthritis Patients in Employment: Results of a Survey Among French Patients
Fagnani, F. / Duburcq, A. / Woronoff, A. S. / Chauvin, P. / Cukierman, G. / Tropé-Chirol, S. / Joubert, J. M. / Bertin, P. | 2013
A571
Patterns of Disease Remission Among Patients with Rheumatoid Arthritis Receiving Their First Biologic in European Union
Narayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. | 2013
A572
Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients: A French National Claims Database Analysis Over the Period 2009-2011
Fautrel, B. / Laurendeau, C. / Joubert, J. M. / Cukierman, G. / Gourmelen, J. / Fagnani, F. | 2013
A573
The Resource Use Related to Hip Fractures Based on Data from ICUROS
Wintzell, V. / Ivergård, M. / Tankó, L. B. / Barghout, V. / Svedbom, A. / Alekna, V. / Bianchi, M. L. / Clark, P. / Díaz Curiel, M. / Dimai, H. P. | 2013
A574
The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany
Sroczynski, G. / Esteban, E. / Engel, J. / Hillemanns, P. / Petry, K. U. / Krämer, A. / Schnell-Inderst, P. / Mühlberger, N. / Siebert, U. | 2013
A575
Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer
Luaces, P. / Sánchez, L. / Ballesteros, J. / García, B. / Rodríguez, P. C. / Viada, C. / Popa, X. / Crombet, T. / Lage, A. | 2013
A576
Review of Meta-Analysis Methods for Multinomial Data
Bennison, C. / van Beurden-Tan, C. / Buyukkaramikli, C. / Heeg, B. | 2013
A577
Physician Panels Supporting Clinical Trials and Post-Approval Studies in Oncology: A Willingness-To-Participate Study
Potthoff, P. / Brown, C. / Güther, B. / Eichmann, F. | 2013
A578
Modelling the Cost-Effectiveness of First-Line Biologics for Rheumatoid Arthritis in England and Wales
Righetti, C. / Lebmeier, M. / Pennington, B. / Brereton, N. J. | 2013
A579
Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall: A Systematic Review
Thorn, J. / Noble, S. / Moore, T. / Hollingworth, W. | 2013
A580
The Economic Footprint of the Greek Pharmaceutical Industry
Tserkezis, E. / Paratsiokas, N. / Tsakanikas, A. / Athanasiadis, A. | 2013
A581
Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom
Demuth, D. / Nasuti, P. / Richards, C. / Gray, L. / Price, L. / Magestro, M. | 2013
A582
Evaluation of Dissemination of Brazilian Network for Health Technology Assessment (REBRATS)
Gonçalves, L. / Souza, K. M. / Elias, F. T. | 2013
A583
From Clinical Trial to Real-World Evidence: A Systematic Approach to Identifying Data Sources for Observational Research
Parasuraman, B. / Tomic, K. S. / Winchester, C. C. / Westergaard, M. / Johansson, S. | 2013
A585
Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation Times
Bennett, H. / Tetlow, A. P. / McEwan, P. | 2013
A587
The Role of Simulation Modeling in Planning Long-Term Clinical Trials in Type 2 Diabetes
Foos, V. / Grant, D. / Palmer, J. L. / Lamotte, M. / McEwan, P. | 2013
A589
Literature Review and Assessment to Populate a Decision-Analytic Model Evaluating a Novel Prognostic in Early Lung Cancer
Stenehjem, D. / Jiao, T. / Rhien, T. / Bellows, B. K. / Kaldate, R. R. / Jones, J. / Brixner, D. | 2013
A590
A De Novo Economic Model to Assess the Cost and Quality of Life Consequences of an Intervention for Levodopa Induced Dyskinesia Amongst Patients with Parkinson’s Disease
Bhattacharyya, S. / Sacco, P. / Shirore, R. M. / Sonathi, V. / Thomas, S. | 2013
A591
Appropriate Evidence Sources for Populating Decision Analytic Models Within Health Technology Assessment (HTA): A Systematic Review of HTA Manuals and Health Economic Guidelines
Zechmeister-Koss, I. / Schnell-Inderst, P. / Zauner, G. | 2013
A592
The Role of Half-Cycle Correction in the Models Used for Health Technology Assessment
Nemeth, B. / Vincziczki, . | 2013
A594
A Bayesian Dynamic Model of Asthma in the Real Life
Amzal, B. / Timmaraju, V. / Castelnuovo, E. / Boucot, I. / Pribil, C. / Nachbaur, G. | 2013
A595
Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis
Bergmann, A. / Lang, M. / Bischoff, C. / Schicklmaier, P. / Schiffhorst, G. / Nolting, H. D. / Rellecke, J. / Kunz, E. | 2013
A596
Exploring the Feasibility of the Instrument Used in Determination of Willingness-To-Pay Per Quality-Adjusted Life-Year in Malaysia
Lim, Y. W. / Shafie, A. A. / Hassali, M. A. / Chua, G. N. | 2013
A598
Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand� (Dash) Questionnaire
Golicki, D. / Krzysiak, M. / Strzelczyk, P. | 2013
A599
Validity of QOL Impact Attributions to Specific Diseases: A Multitrait-Multimethod Comparison
Ware, J. E. / Guyer, R. | 2013
A600
Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials: A Content Validity and Psychometric Performance Review
Humphrey, L. / Heron, L. / Pilling, C. / Holloway, L. / Højbjerre, L. / Strandberg-Larsen, M. / Hansen, B. B. | 2013
A602
A Review of Cognitive Interviewing Methodologies During Linguistic Validation of Clinical Outcome Assessments (COAs)
Simon, M. / Sweeney, E. / Moravec, H. | 2013
A603
Parent Ratings of Ability to Consent for Clinical Trials in Fragile X Syndrome
Bailey, D. / Raspa, M. / Wheeler, A. | 2013
A604
Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies: Optimising User Engagement and Addressing Payer Concerns
Tran, J. B. / Hugh-Jones, C. | 2013
A605
Development of a Questionnaire to Evaluate Food-Related Well-Being
Guillemin, I. / Allaert, F. A. / Arnould, B. / Capuron, L. / Dupuy, A. / Ginon, E. / Lecerf, J. M. / Prost, M. / Rogeaux, M. / Urdapiletta, I. | 2013
A606
Differential Item Functioning in a Satisfaction Item Bank
Campillo-�lvarez, . / Rodríguez-Aguilella, A. / Castejón, N. / Cuervo, J. / Rebollo, P. | 2013
A607
The Impact of DSM-5 on the Development of Drugs to Treat Attention-Deficit/Hyperactivity Disorder
Meyers, O. I. | 2013
A608
Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates
Bujkiewicz, S. / Thompson, J. / Sutton, A. / Cooper, N. / Harrison, M. / Symmons, D. P. / Abrams, K. R. | 2013
A610
Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential Methods
Boucher, R. / Abrams, K. R. / Crowther, M. J. / Lambert, P. C. / Wailoo, A. J. / Latimer, N. R. | 2013
A612
Research in Haemophilia B – Studies in a Rare Disease in Times of Requirements for High Evidence Levels
Schopohl, D. / Berger, K. / Schramm, W. | 2013
A613
Proposal of Economic Evaluation Guideline in Japan
Fukuda, T. / Akazawa, M. / Fukuda, H. / Igarashi, A. / Ikeda, S. / Ishida, H. / Kobayashi, M. / Moriwaki, K. / Noto, S. / Sakamaki, H. | 2013
A614
Systematic Review Approaches for HTA: Horses for Courses?
Kenworthy, J. / Langham, J. / Chetty, M. | 2013
A615
Should There Be an Option to “Unrefer� Nice Single Technology Appraisals: Case Study of Aripiprazole for Bipolar I Disorder in Adolescents
Uttley, L. / Kearns, B. / Stevenson, M. | 2013
A616
How Can Health Economic Assessment Methods Help Decision Making in Portfolio Development
Akpo, H. / Popa, C. / Saka, . | 2013
A617
The Importance of Sensitivity Analyses in Health Technology Assessments
Hren, R. | 2013
A618
Effectiveness of the Early Psychosocial Intervention on Institutionalization of Patients with Mild Alzheimer’s Disease and Caregivers’ Quality of Life – An Alsova Study
Martikainen, J. A. / Kautiainen, H. / Väätäinen, S. / Välimäki, T. / Hongisto, K. / Hallikainen, I. / Sivenius, J. / Soininen, H. / Koivisto, A. | 2013
A619
Practice of Cerebroprotectors Consumption in Ukraine
Kuznetsov, I. / Iakovlieva, L. / Ribka, A. / Vasileva, A. / Kyrychenko, O. | 2013
A621
The Annual Treatment and Rehabillitation Costs of Patients with Paraplegia in the Private Health Care Setting in Greece
Tzovolou, K. / Geitona, M. | 2013
A622
Cost-Effectiveness of Somatropin Administration with Increased Adherence Due to Monitoring Compared to Non-Monitored Administration in Patients with Growth Hormone Deficiency
Vitova, V. / Tichopad, A. | 2013
A623
Cost-Effectiveness Analysis of Lacosamide Compared with Standard of Antiepileptic Care Based on Clinical Practice Data
Vocelka, M. / Klimes, J. / Dolezal, T. / Foitova, H. | 2013
A624
Treatment Adherence and Costs in Multiple Sclerosis: A Narrative Review of the Literature
Paz, S. / Comellas, M. / Lizán, L. | 2013
A625
Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQ�
Galera, J. / Munteis, E. / Navarro, G. / Meca, J. / Maestre, A. / Perez, A. / Gracia, J. / Pato, A. | 2013
A626
Evaluating Patient Adherence Rates to Approved Disease Modifying Therapies (DMT) for Relapsing-Remitting Ms (RRMS): Operational Setup for a Multi-Country, Multi-Center Study
Apecechea de Scheffer, M. / Faber, S. / Potthoff, P. / Eichmann, F. | 2013
A627
Additional Clinical Benefit for Patient Relevant Endpoints: Investment Disincentives by AMNOG in the Example of Parkinson’s Disease
Walzer, S. / Holbein, B. | 2013
A628
Drug Compliance and Persistence in Patients with Parkinson’s Disease Treated in Primary Care in the United Kingdom: A CPRD-Based Study
Bineau, S. / Guelfucci, F. / Neine, M. / Aballea, S. / Milea, D. | 2013
A629
A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United States
Jiao, T. / Liou, T. G. / Young, D. / Brixner, D. | 2013
A631
In-Patient Hospitalizations for Chronic Kidney Disease in the United States
Aggarwal, S. / Topaloglu, H. | 2013
A632
Cost and Cost-Effectiveness of Treating Urgency Stress Incontinence-Results from a Randomized Controlled Trial
Kafri, R. / Greenberg, D. / Shames, J. / Novack, L. / Melzer, I. | 2013
A633
Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom
Maman, K. / Neine, M. / Briquet, B. / Nazir, J. / Odeyemi, I. A. / Hakimi, Z. / Garnham, A. / Aballéa, S. | 2013
A634
The Impact of Sacral Neuromodulation on EQ-5D Index Scores and Costs to Manage Overactive Bladder
Hinnenthal, J. / Siegel, S. / Noblett, K. / Mangel, J. / Bird, E. T. / Griebling, T. L. / Comiter, C. | 2013
A635
Antibiotic Utilization in Complicated Urinary Tract Infection in a Tertiary Care Teaching Hospital in South India
Nair, S. / Mathew, J. / Palaye, M. / Faryabi, R. / Shetty, P. / Shivshankar, K. / Thunga, G. / Vijayanarayana, K. | 2013
A637
ISPOR 16th Annual European Congress Disclosure Information
| 2013
A649
ISPOR 16th Annual European Congress Author Index
| 2013
A665
Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto Económico
Contreras, I. / Lopez-Perez, A. / Mendez, G. F. / Mejia-Arangure, E. | 2013
A666
Effect of Health Spending, Income Inequality and Margination Index on the Efficiency of the Health System in Mexico
Pinzon Florez, C. E. / Reveiz, L. / Idrovo, A. J. / Reyes, H. / Diaz de Leon, C. | 2013
A667
Eficácia E Segurança De Ranibizumabe E Bevacizumabe No Tratamento De Degeneração Macular Relacionada a Idade
Saturnino, L. T. / Silveira, M. R. / Guerra Junior, A. A. / Acurcio, F. D. | 2013
A668
Implications of Global Pricing Policies of Pharmaceuticals for Access the Innovative Drugs: The Case of Trastuzumab in Seven Latin American Countries
Pichon Riviere, A. / Garay, U. / Augustovski, F. / Vallejos, C. / Huayanay, L. / Navia, M. D. / Rodríguez, A. / Oliveira, C. / Andrade, C. J. / Buendia, J. A. | 2013
A669
¿Puede un Cambio del 2003 en el Reglamento en el Cuadro Básico (CBM) en México Impactar la Cantidad de Estudios Científicos Publicados de Evaluación Económica Completos de Medicamentos (EECM) en los Últimos 10 Años?
Márquez Cruz, M. / Peralta Bácenas, L. A. / Ibarra Cázares, A. E. / Rodriguez Mendoza, M. M. / Pizarro Castellanos, M. / Soto Molina, H. | 2013
A670
Efecto Del Seguro Popular Salud Sobre La Demanda De Servicios Prenatales En El Contexto De La Cobertura Universal, México 2012
Servan-Mori, E. | 2013
A671
A Multi-National Survey Assessing the Relationship Between Prophylaxis Treatment and Health-Related Quality of Life Among Severe Hemophilia a Patients in Latin America
Perez Bianco, P. R. / Berges, A. / Linares, A. / Moreno, B. / Arvizu, J. / Brabata, C. / Xiong, Y. / Ito, D. | 2013
A674
Fatores Associados À Compra De Medicamentos Em Brasília: Uma Análise Econométrica Com Dados Transversais De Base Populacional
Andrade, C. H. / Wichmann, R. M. / Galvao, T. F. / Pereira, M. G. / Silva, M. T. | 2013
A675
Crescimento De Óbitos Pós Partos Cesarianos No Brasil Versus Partos Normais
Drago, S. / Ferreira, C. N. / Salles, G. R. / Paloni, E. D. / Santana, C. F. / Souza, C. / Bonachela, F. / Abreu, A. A. | 2013
A676
Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En Uci
Beiza, C. / Orrego, N. / Padilla, M. F. / Arriagada, M. J. / Catalan, J. / Fau, C. / Nasabun, V. | 2013
A677
Assessment of Adverse Events By Using Trigger Tools in Surgery Department of an Indian Tertiary Care Teaching Hospital
Vilakkathala, R. / Mallayasamy, S. / Konduru, S. / Rodriques, G. / Manchanapalli, P. / Rao, A. B. | 2013
A678
Comparación Del Trabajo En Equipo En Salas De Cirugía Entre Un Hospital Privado Y Uno Público De Bogotá, D.C
Amaya Arias, A. C. / Eslava-Schmalbach, J. / Barajas Sierra, R. | 2013
A679
Exploring Income Inequality in Self-Reported Health Status in Chile After the Health Care Reform of 2005
Cabieses, B. / Espinoza, M. A. | 2013
A680
A Mediação De Conflitos Na Ação Fiscalizatoria Do Setor De Saúde Suplementar Brasileiro
Tanaka, F. H. / Franco, S. | 2013
A681
Access to Medicines Index: Measuring How Well Countries Provide Access to Medicines
Shankar, R. / Hickson, S. / Gorokhovich, L. | 2013
A682
O Uso De Temozolomida No Tratamento De Astrocitoma De Baixo Grau – Câncer No Cérebro
Gomes, R. M. / Ribeiro Júnior, N. G. / Costa, J. O. / Júnior, A. A. / Acurcio, F. A. | 2013
A684
Direct Medical Costs (DMC) of Treating Chronic Lymphoid Leukemia (CLL) Patients in the Private Health Care System in Brazil: Results from a 12-Month Retrospective Analysis of an Administrative Database
Paloni, E. D. / Ferreira, C. N. / Asano, E. / Santana, C. F. / Pereira, M. L. | 2013
A685
Análisis De Costo-Efectividad De Erlotinib En El Tratamiento De Pacientes Con Cáncer Pulmonar De Células No Pequeñas, CPCNP, Con Mutación Del Gen EGFR+, En Colombia
parada Vargas, L. A. / Barbosa, D. A. | 2013
A686
Tratamento Do Câncer Colorretal Metastático Com Bevacizumabe E Cetuximabe: Acesso E Impacto Econômico Em Um Hospital Universitário
Ungari, A. Q. / Pereira, L. R. / Nunes, A. A. / Peria, F. M. | 2013
A687
Comparación Indirecta De La Efectividad De La Combinación De Hipoglucemiantes Asociados a Metformina En Pacientes Diabéticos Tipo 2
Sanchez, O. / Romero, M. | 2013
A688
Direct Costs of Type 2 Diabetes in Mexico from the Public Health Care Sector Perspective
Chatzitheofilou, I. / Babineaux, S. M. / Ramírez-Gámez, J. / McDonell, A. / Vega-Hernandez, G. | 2013
A689
A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in Mexico
Teschemaker, A. R. / Neslusan, C. / Puig, A. / Valencia, A. / Johansen, P. / Willis, M. | 2013
A690
Impacto De La Diabetes Sobre La Productividad En Argentina
Asteazaran, S. / Elgart, J. / Gagliardino, J. J. | 2013
A691
Influence of One Week Education Program on the Knowledge and Approach of Pharmacy Students Towards Diabetes Mellitus
Khan, M. S. / Akhtar, N. / Ali, A. | 2013
A692
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile
Garcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Garay Ulises, U. / McMullen, M. / Rey Ares, L. / Peirano, I. / Oksenberg Reisberg, D. / Soza Ried, A. / Poniachik, J. | 2013
A693
Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed with Non-Psychotic Major Depressive Disorder: A Literature Review
Greene, N. / Greene, M. | 2013
A694
The Impact of Antipsychotics Polypharmacy on Health Care Costs of People with Mental Disorders in São Paulo City, Brazil
Razzouk, D. / Sousa, A. / Oliveira, G. G. / Cardoso, A. / Mari, J. J. | 2013
A695
Contribution of Latin America to Mental Health in Pregnancy
Lorenzo, L. S. / Einarson, A. / Einarson, T. R. | 2013
A696
Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En Chile
Castillo-Laborde, C. / Loayza, S. / Aravena, M. / Freile, B. / Castillo-Riquelme, M. | 2013
A697
Impacto Presupuestal De La Enfermedad Renal Terminal En Colombia Con Un Incremento Del Número De Trasplantes
Rosselli, D. / Rueda, J. D. / Díaz, C. E. | 2013
A698
Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Compared to Basiliximab in the Induction of Renal Transplant Patients
Escudero, P. / Misas, J. D. / Orozco-Cabal, L. F. | 2013
A699
Estudios Del Coste De La Enfermedad
Crespo, C. / Gisbert, R. / Brosa, M. | 2013
A700
Analysis of Mandibular Test Specimens Used to Evaluate Bone Fixation Systems
Passeri, L. A. / Baccarin, L. S. / Casarin, R. C. / Silva, J. V. | 2013
A701
Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En Reumatología: Uso De Los Estudios Económicos
Guzman Vazquez, S. / Rodriguez Mendoza, M. M. / Pizarro, M. / Soto, H. | 2013
A702
Permanent Transvenous Lead Extraction: Factors Influencing the Difficulty of the Procedure
Bontempi, L. / Cerini, M. / Lipari, A. / Vassanelli, F. / Salghetti, F. / Locantore, E. / Belotti, M. / D’Aloia, A. / Vizzardi, E. / Raweh, A. | 2013
A703
Analysis of Consumption of Antihypertensive Drugs in Serbia from 2007 to 2011
Milijasevic, B. / Milijasevic, D. / Tomic, Z. / Sabo, A. / Mikov, M. / Tomic, N. | 2013
A704
Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting in Mexico City
Rely, K. / Ramírez-Neria, P. / Pulido, T. / Escamilla, C. / Alexandre, P. K. / Cañedo, A. / Salinas Escudero, C. | 2013
A705
Cost-Effectiveness of Transcatheter Aortic-Valve Implantation for Severe Symptomatic Aortic Stenosis in Inoperable Patients in the Brazilian Public Health Care System
Nishikawa, A. M. / Paladini, L. / Borges, L. / Queiroga, M. / Lemos, P. / Clark, O. A. | 2013
A706
Correlación Entre Los Niveles De LDL-C Frente Al Riesgo De Presentación De Evento Cardiovascular
Simbaqueba, E. / Romero, M. | 2013
A707
Estimating the Impact of Statin Therapy on Direct and Societal Costs in Mexico: A Comparison to Sweden
Semilla, A. P. / Kowal, S. / Storm, M. / Blanchard, T. | 2013
A708
Análise Comparativa Dos Anticoncepcionais Orais Com Diferentes Concentraçoes De Etinilestradiol Em Relação Aos Perfis De Eficácia E De Adesão
Freitas, M. G. / Silva, A. S. / Elias, F. T. | 2013
A709
Costo-Efectividad De Carbetocina En Comparación Con Oxitocina Para Prevenir Hemorragia Posparto Por Atonía Uterina En Pacientes Con Factores De Riesgo En Colombia
Rueda, C. / Caceres, L. A. / Caicedo Navas, A. G. | 2013
A710
Measurements of Adherence to Oral Therapies Among Brazilian Patients: A Systematic Review
Takemoto, M. L. / Guerra, R. / Fernandes, R. A. / Pereira, A. C. / Santos, P. M. / Amaral, L. M. / Vasconcellos, J. F. | 2013
A711
Atención Intercultural Del Parto Vaginal En México: Costos Económicos, Determinantes Y Retos De La Implementación De Políticas Efectivas En Beneficio De Las Mujeres Indígenas
Heredia, I. / Meneses, S. / Montag, D. / Ibañez, M. / Hernández, E. / González Block, M. A. | 2013
A712
Costos Económicos Asociados A Secuelas De Meningitis En Colombia
Alvis-Guzmán, N. / Coronell-Rodriguez, W. / Castañeda-Orjuela, C. A. / De la Hoz-Restrepo, F. | 2013
A713
The Health and Economic Impact of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) in Columbia: A Transmission Dynamic Model-Based Evaluation
Kothari, S. / Nwankwo, C. / Pillsbury, M. / Shcheprov, A. / Posso, H. | 2013
A714
Pharmacoeconomics of Cervarix Vaccines Against Human Papilloma Virus in the Republic of Kazakhstan
Nurgozhin, T. / Gulyaev, A. / Yermekbayeva, B. / Kushugulova, A. / Akhmetova, A. / Supiev, A. | 2013
A715
Avaliação Do Impacto Orçamentário Com a Incorporação De Imunobiológicos Em Uma Operadora De Planos De Saúde – 2012
Reis, H. P. / Magalhães, D. D. / Vieira, J. B. / Sartori, D. P. / Fonseca, D. B. / Filho, A. E. / Barsi, U. D. / Gontei, M. / Alcantara, A. C. / Maciel, J. A. | 2013
A716
Custos Das Fraturas Osteoporóticas No Sistema Público De Saúde Brasileiro
Brandão, C. M. / Machado, G. P. / Drumond, H. A. / Alemão, M. M. / Acurcio, F. D. | 2013
A717
Estimated Cost Effectiveness of Lower-Dose Submicron Diclofenac Compared with Traditional Diclofenac in Brazil
Mladsi, D. M. / Ronquest, N. / Tannus, G. / Fonseca, M. / Saag, K. | 2013
A718
Qualidade De Vida Dos Pacientes Que Utilizam Medicamentos Anti-TNF Para O Tratamento De Doenças Reumáticas No Sistema Único De Saúde Em Minas Gerais, Brasil
Oliveira Junior, H. A. | 2013
A720
Burden of Multiple Sclerosis and Unmet Needs in Brazil: Cost of Illness Study
Silva, N. L. / Takemoto, M. / Damasceno, B. / Fragoso, Y. D. / Finkelsztejn, A. / Gomes, M. | 2013
A721
Cost-Effectiveness Analyses of Natalizumab for 1st Line Versus Interferon Beta-1a 44 Mcg in the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis Patients in Brazil
Nishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. | 2013
A722
Evaluation of Treatment Patterns and Clinical Trials Published on Patients Diagnosed with Insomnia: A Literature Update
Greene, N. / Greene, M. | 2013
A723
Health and Economic Burden of Tobacco Use in Seven Latin American Countries: Results from a Microsimulation Health Economic Model (HEM)
Pichon Riviere, A. / Bardach, A. / Caporale, J. / Augustovski, F. / Alcaraz, A. / Navia, M. D. / Pinto, M. / Vallejos, C. / Peña Torres, E. / Reynales, L. M. | 2013
A725
Efficacy and Safety of Belimumab for the Treatment of Systemic Lupus Erythematosus
Borba, H. H. / Wiens, A. / Correr, C. J. / Pontarolo, R. | 2013
A726
Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones Clínicas Mucocutáneas De La Enfermedad De Behcet
Quirland Lazo, C. | 2013
A727
Orphan Drug Access: Risk/Reward Analysis of Local Clinical Development in Chile
Ismail, A. / Dummett, H. | 2013
A729
ISPOR 4th Latin America Conference Disclosure Information
| 2013
A732
ISPOR 4th Latin America Conference Author Index
| 2013
I
Instructions for Authors
| 2013
i
Table of Contents
| 2013
Study of Antibiotic Consumption Pattern in Hospital Acquired Pneumonia
Kunhikatta, V. / Rau, N. R. / Naik, A. N. / Yamsani, B. / Thunga, G. / Nair, S. | 2013
Hospital Admissions Related to Tuberculosis in Brazil: Epidemiological and Economic Profile, from the Public Health Care Perspective
Amaral, L. M. / Fernandes, R. A. / Takemoto, M. / Vasconcellos, J. F. / Haas, L. C. / Silva, M. A. / Menezes, L. P. | 2013
Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece
Karabela, P. / Efklidou, E. / Lyberopoulou, E. / Panagopoulou, C. / Standaert, B. | 2013
Pharmacoeconomic Analysis of Progestogen Preparations for Threatened Abortion Treatment in Ukraine
Tkachova, O. / Iakovlieva, L. / Mishchenko, O. / Matyashova, N. | 2013
Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales
Lion, M. / McCann, E. / Jiang, Y. | 2013
An Economic Model to Compare Linezolid and Vancomycin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
Patel, D. A. / Michel, A. / Stephens, J. M. / Weber, B. / Gao, X. / Charbonneau, C. | 2013
Three Years of the Gefitinib UK Single Patient Access (SPA) Scheme: Duration of Treatment for Patients with EGFR Mutation Positive NSCLC in NHS Clinical Practice
Vioix, H. / Franzen, S. / Selby, D. / Collomb, D. / Hauch, O. / Emmas, C. | 2013
Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children: A Discrete Choice Experiment
Veldwijk, J. / Lambooij, M. S. / Bruijning-Verhagen, P. C. / Smit, H. A. / de Wit, G. A. | 2013
Validation and Psychometric Evaluation of the German-Translated Hepatitis C Virus Patient Reported Outcomes (HCV-PRO) Health and Wellbeing Instrument in German HCV-Infected Patients Treated with Direct Acting Antivirals (DAAS) with or Without Ribavirin (RBV)
Anderson, R. T. / Baran, R. W. / Xie, W. / Liu, Y. / Dietz, B. / Gooch, K. L. | 2013
Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality: A European Overview
Hanly, P. / Soerjomataram, I. / Sharp, L. | 2013
Paper-Based and Electronic Assessment of Health-Related Quality of Life Specific to HIV Disease: A Reliability Study with the PROQOL-HIV Questionnaire
Lalanne, C. / Herrmann, S. / Armstrong, A. R. / Cheung-Lung, C. / Schwartz, Y. / Chassany, O. / Duracinsky, M. | 2013
Chemotherapy Treatment Patterns, Health Care Costs, and Mortality of Lung Cancer Patients in Taiwan – A Longitudinal Study Between 2000 and 2008
Liang, F. W. / Chen, S. Y. / Tsai, C. F. / Jen, M. H. / Li, C. Y. / Wasiak, R. / Boulanger, L. / Lu, T. H. | 2013
Selective Internal Radiotherapy (SIRT) Using Resin Yttrium-90 Microspheres for Chemotherapy-Refractory Metastatic Colorectal Cancer: An Italian Cost-Effectiveness Analysis
Cosimelli, M. / Golfieri, R. / Pennington, B. / Sennfält, K. | 2013
A Cost-Effectiveness Analysis of Axitinib and Sorafenib for 2nd Line Treatment of Advanced Renal Cell Carcinoma After Failure of Cytokines in the United States
Stillman, I. O. / Ambavane, A. / Cislo, P. | 2013
Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain
López Belmonte, J. L. / Cortés Bordoy, J. / Gil de Miguel, A. / Bresse, X. / Serip, S. / Nieves, D. / Bosch, X. | 2013
Cost-Effectiveness of Breast Cancer Surveillance by Lifetime Risk in Women Aged Less Than 50 Years
Teljeur, C. / Harrington, P. / Murphy, L. / Ryan, M. | 2013
Health Technology Assessments of Medical Devices: Is Help Out There?
Green, W. / Wood, H. | 2013
The Impact of Cost Effectiveness on Reimbursement Approvals in France: A Comparison of France and the United Kingdom
Purchase, J. L. / Nijhuis, T. | 2013
Health State Utility Values in Advanced Non-Small Cell Lung Cancer Patients
Chevalier, J. / Le Lay, K. / de Pouvourville, G. | 2013
Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial
Connolly, M. / Currie, C. / Chang, J. | 2013
Barriers Underlying Limited Utilisation of Vaccines Throughout Life (Lifespan Immunisation)
Ghosh, S. / Tangari, M. / Baron-Papillon, F. / Sauty, E. / Rodriguez de Azero, M. / Adel, A. l. | 2013
WITHDRAWN
| 2013
Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations: Results from Patients in the Quest-1, Quest-2, and Promise Studies
Scott, J. / Gilles, L. / Fu, M. / Brohan, E. / Amatya, R. / Jessner, W. / Beumont-Mauviel, M. | 2013
Economical Justification of the Innovation Method of Laboratory Diagnostic of the Structural and Functional Changes of Serum Albumin in Septic Complications (Ata-Test)
Vorobiev, P. / Bezmelnitsyna, L. / Krasnova, L. / Muravsky, V. / Davidova, T. / Sytov, A. | 2013
Cost-Effectiveness Analysis of Carbapenems in Treatment Nosocomian Pneumonia in Ukraine
Iakovlieva, L. / Bezditko, N. / Glumcher, F. / Dubrov, F. | 2013
Economic Evaluation of Enhanced Asthma Management: A Systematic Review
Yong, Y. V. / Shafie, A. A. | 2013
Cost-Effectiveness of Sugammadex for Routine Reversal of Neuromuscular Blockade, with Extubation at a TOF Ratio of 0.9, in Anaesthetised Patients Undergoing Elective Surgery in England and Wales
Praet, C. / D’Oca, K. / O’Regan, C. / Insinga, R. P. / Maiese, E. M. | 2013
Cost Analysis of a Fibrin Sealant Patch for Mild, Moderate and Problematic Soft Tissue Surgical Bleeding: A Hospital Perspective
Corral, M. / Ferko, N. / Hollmann, S. / Delatore, P. / Jamous, N. / Brown, S. T. / Rubinger, D. | 2013
Disease Status, Treatments and Outcomes of Patients with Ankylosing Spondylitis Receiving Their First Biologic in the United States and European Union
Narayanan, S. / Baskett, A. / Lu, Y. / Hutchings, R. | 2013
Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China
Yang, Y. / Du, F. / Lu, T. / Xie, Z. / Xu, W. / Huang, Q. / Ye, W. W. / Burge, R. | 2013
The Cost Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Hepatitis C in Children and Young People
Cooper, K. / Baxter, L. / Loveman, E. / Hartwell, D. / Frampton, G. | 2013
Disposición a Pagar Y Análisis De Conjoint Para Determinar Las Preferencias Por Los Productos Medley En México
Camacho, A. / Soto, H. | 2013
Cost Effectiveness Evaluation of a Rotavirus Vaccination Program in Argentina
Garcia Marti, S. / Alcaraz, A. / Valanzasca, P. / Mc mullen, M. / Standaert, A. / Garay, U. / Lepetic, A. C. / Gomez, J. A. | 2013
Evolución Del Consumo Y Ventas De Antibióticos En Chile 1998-2012
Villagra, G. / Jirón, M. | 2013
Pathological Gambling: A Growing Addiction
Dannon, P. | 2013
Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework
Brodszky, V. / Gulacsi, L. / Balogh, O. / V. Hevér, N. / Baji, P. / Péntek, M. | 2013
Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients?
Mohamed, A. F. / Johnson, F. R. / Balp, M. M. / Calado, F. | 2013
The Measurement of Health-related Quality of Life: German Findings from the Multi-Instrument Comparison (MIC) Study
Schlander, M. / Khan, M. A. / Iezzi, A. / Maxwell, A. / Richardson, J. | 2013
A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection
Younossi, Z. M. / Gordon, S. / Saab, S. / Ahmed, A. / Cure, S. / Guerra, I. | 2013
The Growing Role of Qualitative Interviews in Health Outcomes Research
Guillemot, J. / Gauthier, A. / Hass, B. / Basso, F. / Cognet, M. | 2013
The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe
Lyons, E. J. / McGeagh, J. / Es-Skali, I. J. / Parmenter, L. / Nijhuis, T. / Boucher, G. | 2013
Co-administration of Antipsychotics and Anti-dementia Drugs in Austria
Hinteregger, M. / Füzi, J. / Reichardt, B. | 2013
Protective Factors for University Students’ Health
Višnjić, A. / VeliÄÂkoviÄÂ, V. / Sokolović, D. / Ranđelović S, S. / MilovanoviÄ Â, M. | 2013
Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States
Fan, W. / LaPensee, K. / Mao, J. / Iorga, S. / Lodise, T. P. | 2013
Economic Implications of Alternative Treatments and Care Locations for Acute Bacterial Skin and Skin Structure Infections with Suspected MRSA
LaPensee, K. / Fan, W. / Revankar, N. / Ward, A. / Kongnakorn, T. / Pelligra, C. | 2013
Cost-Effectiveness Analysis of Empiric Liposomal Amphotericin B Versus Voriconazole in Turkey
Turner, S. J. / Senol, E. / Kara, A. / Al-Badriyeh, D. / Kong, D. C. / Dinleyici, E. C. | 2013
The Health and Economic Effects on Public Health Due to Patients’ Default in Tuberculosis Treatment in Malaysia
Fun, W. H. / Wu, D. B. / Cheong, Y. M. / Mohd Noordin, N. / Dony, J. F. / Lee, K. K. | 2013
Cost of Microvascular and Macrovascular Complications in Peoples with Diabetes Type 1 and Type 2 in Bulgaria
Dimitrova, M. / Doneva, M. / Vulov, V. / Manova, M. / Savova, A. / Petrova, G. / Czech, M. | 2013
The Cost of Producing a Unit of Blood in Hospitals: A Nationwide Economic Analysis for the Case of Greece
Fragoulakis, V. / Stamoulis, K. / Grouzi, E. / Maniadakis, N. | 2013
Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians
Khan, Y. / Sharriff, A. / Khan, A. H. | 2013
Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt
ElSisi, G. / Elmahdawy, M. / Abaza, S. / Shalakani, A. | 2013
The Cost of NSCLC in France
Martin, M. / Mcguire, A. / Marty, R. / Lenz, C. | 2013
Impact of Dosage and Seven Other Factors in the Adherence to Oral Medication in People with Diabetes Type 2 in Germany
Pleguezuelo, W. i. | 2013
A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes: The Korea National Health and Nutrition Examination Survey
Lee, J. Y. / Lee, E. K. | 2013
A Lesson Learnt from Avastin®: - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles
Fowler, R. C. / Street-Docherty, L. M. / Morrison, S. | 2013
Health Care Utilization Following Newly-Diagnosed Type-2 Diabetes in Sweden: A Follow-Up of 38,956 Patients in a Real Clinical Setting
Sabale, U. / Bodegård, J. / Sundström, J. / Svennblad, B. / Östgren, C. J. / Nilsson, P. / Johansson, G. / Henriksson, M. | 2013
Efficacy of Brentuximab Vedotin and Other Treatments in Patients with Relapsed or Refractory (RR) Systemic Anaplastic Large-Cell Lymphoma (SALCL): A Systematic Review
Bonthapally, V. / Yang, H. / Macalalad, A. R. / Wu, E. Q. / Lutes, R. / Shonukan, O. / Chi, A. / Huebner, D. | 2013
Skeletal-Related Events Have a Significant Impact on Health-Related Quality of Life in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) Following Docetaxel Therapy Failure
Ivanescu, C. / Phung, D. / Holmstrom, S. | 2013
Economic Evaluation of Epoetin Alfa Hexal (Binocrit) Compared to Darbepoetin Alfa (Aranesp) in the Treatment of Chemotherapy Induced Anemia (CIA) in Germany
Turner, M. / Walsh, K. / Whitehouse, J. | 2013
Real World Management and Costs in Unresectable Metastatic Melanoma (MM) Patients: Update of a Pilot Study Based on an Institutional Patient Registry
Strens, D. / Specenier, P. / Peeters, M. | 2013
Correlations Between Changes in the Urticaria Activity Score (UAS7) and the Dermatology Life Quality Index (DLQI) from Baseline to 28 or 40 Weeks: Comparisons of Trajectories of Change in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU)
Stull, D. E. / McBride, D. / Balp, M. M. / Gnanasakthy, A. | 2013
Antithrombotic Strategies and Adverse Outcomes in Acute Coronary Syndrome and Atrial Fibrillation: A Community Study
Chamberlain, A. M. / Gersh, B. J. / Klaskala, W. / Mills, R. M. / Alonso, A. / Weston, S. A. / Roger, V. L. | 2013
A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintenance for Non-Squamous NSCLC in Sweden
Bryden, P. A. / Kumar, G. / Winfree, K. B. / Boye, M. E. / Taipale, K. / Thompson, R. / Borgeke, H. | 2013
Cost Assessment of Metastatic and Non-Metastatic Castration-Resistant Prostate Cancer Patient-Management in Spain
Morote, J. / Cozar, J. M. / Duran, I. / Gomez Veiga, F. / Leon, L. / Maroto, P. / Miñana, B. / Solsona, E. / Oyagüez, I. / Casado, M. A. | 2013
Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer
Aggarwal, S. / Segal, J. / Kumar, S. | 2013
The Effectiveness of Statins in the Treatment of Cardiovascular Disease: Cross-Sectional Study with Paired Groups from Electronic Patient Records
Abrahão, M. T. / Nobre, M. R. / Gutierrez, M. A. | 2013
Defining Eligible Patient Population in São Paulo State Based on Cleopatra Trial Inclusion Criteria: A Retrospective Analysis of Fundação Oncocentro (FOSP) Cancer Patient Registry (Registro Hospitalar Do Câncer – RHC)
Tobaruella, F. S. / Maximo, M. F. / Tsuchiya, C. T. / Buschinelli, C. T. / Gonçalves, T. M. | 2013
Cost-Comparison Between Different Treatment Regimens in Diabetes Mellitus in Germany Based on Long Acting Insulins
Anderten, H. / Dippel, F. W. / Schneider, T. | 2013
Adrenal Insufficiency: Burden of Disease and Cost of Illness
Chauhan, R. / Lee, D. | 2013
The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Insulin in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales
Charokopou, M. / McEwan, P. / Lister, S. / Callan, L. / Bergenheim, K. / Tolley, K. / Roudaut, M. | 2013
How Does Hospitalization Impact Insulin Treatment in Diabetes Mellitus? Results of a Retrospective German Database Analysis
Schmidt, J. / Dippel, F. W. / Steinmeier, T. | 2013
Treatment Satisfaction and Its Association with Health Outcomes in Patients with Neuropathic Pain
Holbrook, T. / Obradovic, M. / Liedgens, H. | 2013
Profile of Back Pain Sufferers Across 5EU Countries
Annunziata, K. / Isherwood, G. / Sternbach, N. | 2013
The Effect of Reduced or Removed Copayments for Prescription Medicines on Adherence – A Systematic Review
Sinnott, S. J. / Sinnott, C. M. / Whelton, H. | 2013
Advanced Budget Notification (ABN): Is There a Win:Win for Manufacturers and Payers Given the Current Austerity Measures Across the EU
Mallinson, M. | 2013
Consumption of Biosimilar Drugs in Campania Region in the Years 2009-2012
Menditto, E. / Cammarota, S. / Putignano, D. / Orlando, V. / Fiorentino, F. | 2013
Health-Related Quality of Life in Patients Along First Year Poststroke in Spain
�lvarez Sabín, J. / Masjuan, J. / Torres, C. / Mar, J. / Oliva, J. / González-Rojas, N. | 2013
Simulating the Potential Impact of Improved Blood Pressure Control on Clinical and Economic Outcomes in Russia
Kontsevaya, A. / Alperin, P. / Shum, K. / Eriksson, J. A. / Vigdorchik, A. / Shalnova, S. / Boytsov, S. / Hughes, D. | 2013
The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need
Dionne, P. A. / Ali, F. / Grobler, M. | 2013
Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes
Lachaine, J. / Beauchemin, C. | 2013
Análisis De Costos Mediante Un Modelo Lineal Generalizado De Pacientes Mexicanos Con Sindrome De West
Pizarro, M. / Soto, H. / Bastida-Mercado, E. / Salazar, A. | 2013
Health Economic Benefits of Sensor Augmented Insulin Pump Therapy in Colombia
Gomez, A. / Alfonso-Cristancho, R. / Prieto-Salamanca, D. / Valencia, J. E. / Lynch, P. / Roze, S. | 2013
Characteristics of Children and Adolescents Using Proton Pump Inhibitors or Histamine-2-Receptor Antagonists: Analysis of Thin and Pharmo Databases
Ruigómez, A. / Houweling, L. M. / García-Rodríguez, L. A. / Penning-van Beest, F. J. / Herings, R. M. | 2013
Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil
Nishikawa, A. M. / Paladini, L. / Liamas, A. L. / Bueno, C. C. / Clark, O. A. | 2013
Análise De Custo-Efetividade Para Utilização De Oclusores Septais No Fechamento De Comunicação Interatrial (CIA) Do Tipo Ostium Secundum Comparado Com a Cirurgia Convencional
Costa, M. G. / Santos, M. S. / Correia, M. G. / Santos, B. / Correia, M. I. / Cintra, M. A. / Almeida, J. M. / Souza, T. F. | 2013
Disease Burden of Ischemic Stroke Along First Year Post-Stroke in Spain
�lvarez Sabín, J. / Masjuan, J. / Yébenes, M. / Mar, J. / Oliva, J. / González-Rojas, N. | 2013
Screening Strategies for Heart Failure in Patients with Type 2 Diabetes: Assessing Cost-Effectiveness in Those Aged 60 Years or Over
van Giessen, A. / Boonman-de Winter, L. J. / Rutten, F. H. / Cramer, M. J. / Landman, M. J. / Liem, A. H. / Hoes, A. W. / Koffijberg, H. | 2013
Total Costs and Outcomes of Drug-Eluting Stent Placement with Intravascular Ultrasound (IVUS) Compared with Angiography Alone: A Cost-Effectiveness Analysis from the Perspective of the Italian Health System
Wasserman, M. / Priest, V. / Alberti, A. / Gelera, A. / Stefanini, L. / Simmonds, M. | 2013
Prescribing Patterns of Parkinson’s Disease
Tomita, N. / Kanatani, Y. | 2013
Custo-Efetividade Do Tratamento Para Osteoporose Na Pos-Menopausa No Brasil
Brandão, C. M. / Machado, G. P. / Saturnino, L. T. / Oliveira, G. L. / Acurcio, F. D. | 2013
Costo-Efectividad De Las Cintas De Uretra Media Comparadas Con El Tratamiento Convencional De La Incontinencia Urinaria Femenina De Esfuerzo En Colombia
Lopez-Ramos, H. E. / Garcia-Perdomo, H. / Prieto-Martinez, V. / Rosselli, D. / Cortes, V. | 2013
Resource Utilization and Costs for Patients with Inflammatory Bowel Diseases in Italy: A Population-Based Assessment
Madotto, F. / Fornari, C. / Fiorino, G. / Ardizzone, S. / Bortoli, A. / Caprioli, F. / Cestari, R. / Conti, S. / Cortelezzi, C. / Mantovani, L. G. | 2013
Estimating the Cardiovascular Benefits of DPP-4 Inhibitors: A Simulated Study
Schuetz, C. A. / Ong, S. H. / Yeung, T. / Blüher, M. | 2013
Graphic Health Warnings on Cigarette Packs in Qatar: Pre-Implementation Awareness and Perception Among the General Public
Awaisu, A. / Hagi, A. / Ashour, M. A. / Kheir, A. N. | 2013
Scoring the Center for Epidemiologic Studies – Depression Scale: Which Items Go Where?
Cole, J. C. / Atkinson, M. J. / Nokela, M. | 2013
Assessing the Economic Burden and Health Care Utilizations of the United States Veteran Patients Diagnosed with Schizophrenia
Wang, L. / Xie, L. / Li, L. / Kariburyo, M. F. / Baser, O. | 2013
The 3D O-Arm Surgical Imaging System with Navigation Effectively and Economically Addresses the Challenges of Spinal Stabilization Procedures
Annoni, E. / Joedicke, H. / Barnett, G. S. | 2013
Cost-Effectiveness Analysis of Incorporation of the HPV Vaccine to the National Immunization Program / NIP of Brazil
Novaes, H. M. / azevedo e Silva, G. / Ayres, A. / Itria, A. / Rama, C. / Sartori, A. M. / De Soarez, P. C. / Clark, A. / Resch, S. | 2013
Cost-Effectiveness of Paricalcitol Versus Parathyroidectomy for Secondary Hyperparathyroidism to Chronic Kidney Disease in Mexico
Sanchez-Casillas, J. L. / Ramirez-Lopez-De-N, M. G. | 2013
Costo Del Automonitoreo Glucémico En Pacientes En Tratamiento Combinado Oral Y Con Insulina En Argentina
Elgart, J. / Gonzalez, L. / Gagliardino, J. J. / Rucci, E. | 2013
The Direct Costs of Drug-Induced Skin Reactions in Poland
Wisniewska, N. / Szkultecka-Debek, M. / Owczarek, W. / Paluchowska, B. / Jahnz-Rozyk, K. | 2013
The Cost-Effectiveness and Cost-Utility of Paliperidone Palmitate in the Treatment of Schizophrenia in Guatemala
Obando, C. A. / Gonzalez, L. / Muschett, D. | 2013
Comparative Efficiency Research: Meta-Analysis of Cost-Effectiveness Studies
Crespo, C. / Monleon, A. / Díaz, W. / Rodriguez, C. / Brosa, M. / Rios, M. | 2013
Health Related Quality of Life of Patients with Bladder Cancer in Hungary
Brodszky, V. / Szantó, . / Balló, A. / V. Hevér, N. / Gulácsi, L. / Tóth, G. / Buzogány, I. / Péntek, M. | 2013
Estimación Epidemiologica Del Cácer De Pulmón De Celulas No Pequeñas En México
Peniche-Otero, G. / Herrera-Rojas, J. / Gryzbowski, E. / Muciño-Ortega, E. / Galindo-Suárez, R. M. | 2013
Uncovering the Gap Between Model Validation Recommendations and Practice
Kleintjens, J. / Akpo, H. | 2013
A Comparison of the Relative Weights of Health Domains on Global Retrospective and Experienced Health and Well-Being
Joore, M. A. / Delespaul, P. A. / White, M. P. / Maes, I. | 2013
The Determinants of Innovation – A Brief Study of Issues Influencing Innovation in the Pharmaceutical Industry
Ghouse, R. | 2013
A Review of Clinical Trial Simulation Methods
Schuetz, C. A. / Ong, S. H. | 2013
Using Lower Cost, Lower Efficacy Interventions Can Improve Population Health Outcomes Under Budget Constraints
Arbel, R. / Greenberg, D. | 2013
Health Care Resource Utilization and Cost Among Natalizumab Initiators with Multiple Sclerosis in the United States
Bonafede, M. M. / Johnson, B. H. / Watson, C. | 2013
Direct and Indirect Costs of MS in Ireland
Fogarty, E. / Walsh, C. / McGuigan, C. / Barry, M. / Tubridy, N. | 2013
Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)
Kryskowiak, P. / Viallet, F. / Brefel-Courbon, C. / Durif, F. / Ory-Magne, F. / Tison, F. / Bourdeix, I. / Rérat, K. / Willemin, L. | 2013
Economic Impact Associated with a Biological Therapy Prioritization Protocol in Rheumatoid Arthritis Patients in the Hospital of Sagunto
Borrás-Blasco, J. / Gracia-Pérez, A. / Castera, D. E. / Rosique, J. D. / Abad, F. J. / González, l. A. | 2013
Costo E Impacto Presupuestal Del Tratamiento Del Cáncer De Púlmon De Celulas No Pequeñas Del Tipo Adenocarcinoma Con Grado Ecog 0,1,2 En Estadio Iv Con Mutación + (EGFR O ALK) Con Terapias Blanco En México
Peniche-Otero, G. / Herrera-Rojas, J. / Gryzbowski, E. / Muciño-Ortega, E. / Galindo-Suárez, R. M. | 2013
Quality of Life in Patients with Multiple Sclerosis in Slovakia
Bielik, J. / Tomek, D. / Tomekova, K. / Novak, I. / Andrasova, E. | 2013
Treatment of Type 2 Diabetes with Saxagliptin/Metformin Extended-Release (XR): Budget Impact Analysis in Argentina
Elgart, J. / Gonzalez, L. / Aiello, E. C. / Gagliardino, J. J. | 2013
Affordability of Antihypertensive Treatment in Mexico
Lemus, F. / Rivas, R. | 2013
Evaluation of a Process of Care Model for Open Intravesical Ureteral Reimplantation from a Contemporary Health Care Perspective
Ellsworth, P. / Butler, C. | 2013
Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico
Wehler, E. / Leyva, V. / Bertwistle, D. / Munakata, J. / Valencia, A. / Hernandez, A. / de la Torre, L. / Gonzalez, L. | 2013
Ações De Farmacovigilância: Relato De Notificações De Medicamentos À Agência Nacional De Vigilância Sanitária (ANVISA) – Brasil
Costa Paulo, P. T. / Pedrosa, M. D. / Melo, R. D. / Fernandes, A. D. | 2013
Analysing the Access to Priority Health Services in the Adolescent Population in Six Provinces in Northern Argentina
Maceira, D. | 2013
Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En Colombia
Mould, J. / Ordoñez, J. / Gutierrez-Ardila, M. V. / Vargas Zea, N. | 2013
Emerging Cardiovascular Events Associated with Targeted Anticancer Drugs. Preliminary Results of a Care Line’s Program Based on Audit Vigilance in a Private Health Care in Brazil
Tanaka, E. / Da Costa, E. S. / Santos, G. L. / Michaelis, W. / Miguel Neto, C. / Ribas, K. M. / Mischiatti, E. / Kotze, O. H. | 2013
Differences in Approach to Biosimilars: Nice Versus SMC Recommendations
Izmirlieva, M. / Ando, G. | 2013
Cost of Influenza in Germany
Anastassopoulou, A. / Wahle, K. / Hain, J. / Schroeder, C. / Ehlken, B. | 2013
How Much Does Benign Prostatic Hyperplasia Cost? A Budget Impact Analysis on Italian Patients Treated with 5α-Reductase Inhibitors
Povero, M. / Pitrelli, A. / Pradelli, L. | 2013
Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease
Burgers, L. T. / Redekop, W. K. / Severens, J. L. | 2013
The Relative Efficacy and Safety of Simeprevir and Telaprevir in Treatment-Naïve Hepatitis C Infected Patients in a Japanese Population – A Bayesian Network Meta-Analysis
Bryden, P. A. / Quigley, J. / Scott, D. A. / Kuwabara, H. / Cerri, K. | 2013
A Framework for the Cost-Equality Analysis of Health Care Programmes
Asaria, M. / Griffin, S. / Cookson, R. / Tappenden, P. / Whyte, S. | 2013
Evaluating the Cost-Utility of Fenofibrate Treatment of Diabetic Retinopathy in Australia
Valentine, W. J. / Pollock, R. F. / Carr, E. / Aubonnet, P. / Mitchell, P. / Keech, A. | 2013
Lower Short-Term Health Care Cost with the Accu-Chek Aviva Expert System in Multiple Daily Insulin Injection (MDI) Treated Diabetes Patients - Learnings from the Automated Bolus Advisor Control and Usability Study (ABACUS)
Fortwaengler, K. / Parkin, C. G. / Koehler, W. / Cavan, D. A. / Ziegler, R. / Cranston, I. / Barnard, K. / Mast, O. / Schweitzer, M. A. / Wagner, R. S. | 2013
Inhaled Corticosteroids (ICS) in Treatment of Moderate and Severe Asthma in Russian Federation – Comparative Pharmacoeconomic Study
Krysanov, I. / Tyapkina, M. | 2013
Cost of Achieving Relevant Composite Endpoint of HbA1c<7%, No Hypoglycaemia and Weight Loss of ≥3% in a 52 Week Post-Hoc Analysis of Dapagliflozin Versus Glipizide
Bergenheim, K. / Grandy, S. / Wygant, G. D. | 2013
Economic Impact of a Smoking Cessation Program in Mexico: Enrolling Employees and Employers
Huicochea-Bartelt, J. L. / Muciño-Ortega, E. / Hernandez-Reyes, F. C. | 2013
Health Care Resource Utilization and Costs Associated with Treatment of Polish Acromegalic Patients with Lanreotide Autogel 120 Mg – A Retrospective Observational Cohort Analysis
Orlewska, E. / Kos-Kudla, B. / Sowinski, J. / Sworczak, K. / Zgliczynski, W. | 2013
Impact of Patient Weight Trajectory on Cost-Effectiveness of Treatments of Type 2 Diabetes Mellitus (T2DM)
Schroeder, M. / Willis, M. / Johansen, P. / Girod, I. / Neslusan, C. / Thompson, G. | 2013
The Sustainability of Irish Pharmaceutical Expenditure
Walshe, V. / Kenneally, M. | 2013
Troika in Portugal: Pharmaceutical Sector from Paper to Reality
Teixeira, I. / Mendes, Z. / Guerreiro, J. P. / Costa, S. | 2013
Pivotal Studies of Orphan Medicinal Products – an Analysis of Quality of Clinical Evidence
Picavet, E. / Cassiman, D. / Hollak, C. E. / Maertens, J. / Simoens, S. | 2013
A Systematic Review of the Effectiveness of Taxes in Preventing Obesity Trends
Maniadakis, N. / Kourlaba, G. / Kapaki, V. / Damianidi, L. | 2013
A Cost-Analysis of Stereotactic Radiotherapy in Lung Cancer
Perrier, L. / Morelle, M. / Pommier, P. / Plommet, N. / Beckendorf, V. / Mahé, M. A. / Lartigau, E. / Boisselier, P. / Bondiau, P. Y. / Touboul, E. | 2013
Long-Term Survival After Intensive Care Unit Discharge in Thailand: A Retrospective Study
Luangasanatip, N. / Hongsuwan, M. / Lubell, Y. / Limmathurotsakul, D. / Teparrukkul, P. / Chaowarat, S. / Day, N. P. / Graves, N. / Cooper, B. S. | 2013
The Cost of Treating Squamous Cell Carcinoma of the Anus (SCCA) in England: Results from an Empirically Calibrated Model
Keeping, S. T. / Carroll, S. M. | 2013
Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective: A Retrospective Analysis of the Orizon Database
Ferreira, C. N. / Paloni, E. D. / Asano, E. / Santana, C. F. / Pereira, M. L. | 2013
Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System
Kececioglu, S. / Ulus, P. / Cukadar, F. / Ozkan, M. / Urganci, B. | 2013
Are Head-To-Head Data Necessary to Gain Reimbursement in the French National Health Care System?
Patel, A. / Grosfeld, D. / Conti, C. C. / Zaidi, Q. / Furniss, S. J. | 2013
Systematic Literature Review of Economic Burden of Chronic Plaque Psoriasis
Feldman, S. R. / Burudpakdee, C. / Gala, S. / Mallya, U. | 2013
The Attendance of the Fourth Screening Round (2008-2009) of the Hungarian Organized, Nationwide Breast Cancer Screening Program
Boncz, I. / Dobrossy, L. / Péntek, Z. / Kovács, A. / Budai, A. / Vajda, R. / Sebestyén, A. | 2013
Mortality and Medical Costs Associated with Liver-Related Diseases Among Patients with Hepatitis C Virus(HCV) Infection in Taiwan
Tang, C. H. / Huang, K. C. / Huang, S. Y. / Wu, Y. T. / Lin, K. D. | 2013
The Health of Health Technology Assessment in Ireland: Five Points for Improvement
O’Mahony, J. / O’Neill, C. | 2013
Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?
Petryszyn, P. / Staniak, A. | 2013
The Funding of Orphan Medicines in Europe: Payers Achilles’ Heel?
Rietveld, A. / Brown, C. / Johnson, N. / Spoors, J. | 2013
Does HTA Process Help to Achieve the Health Objectives of the Millennium? A South American Analysis
Sansone, D. / Decimoni, T. C. / Etto, H. / Santos, A. M. / Araújo, G. / Fonseca, E. / Fonseca, M. | 2013
Quality of Life Improvement with Etanercept in Patients with Moderate/Severe Psoriasis from Central and Eastern Europe, Latin America and Asia
Kemeny, L. / Amaya, M. / Cetkovska, P. / Lee, W. R. / Galimberti, L. R. / Mahgoub, E. / Rahman, M. / Marshall, L. / Tang, B. | 2013
A Community-Based, Case-Control Study Evaluating Mortality Reduction from Gastric Cancer by Endoscopic Screening in Japan
Hamashima, C. / Ogoshi, K. / Okamoto, M. / Shabana, M. / Kishimoto, T. / Fukao, A. | 2013
A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF)
Viada, C. / Ballesteros, J. / Fors, M. / Luaces, P. / Sánchez, L. / Crombet, T. | 2013
Cost-Effectiveness of Routine Infant Vaccination Strategies in Russia: An Economic Evaluation
Yagudina, R. I. / Akimova, Y. I. | 2013
Results of the Post-Marketing Survey of Vildagliptin in France
Eschwège, E. / Attali, C. / Bringer, J. / Simon, D. / Bouee, S. / Kind, B. / Quere, S. / Dejager, S. / Detournay, B. | 2013
Anti-Diabetic Medications Related Severe Hypoglycaemia Risk in Diabetes Type 1 and Type 2 – A Systematic Review of Observational Studies
Paweska, J. / Jakubczyk, M. / Barszcz, E. / Czech, M. / Niewada, M. | 2013
Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context
Abad Paniagua, E. J. / Casado Escribano, P. / Fernández Rodriguez, J. M. / Morales Escobar, F. J. / Canal Fontcuberta, C. / Betegón Nicolás, L. / Capel, M. / Brosa, M. | 2013
The Burden of Pneumonia in Malaysia, Indonesia and Philippines
Aljunid, S. / Namaitjiang, M. / Al-Abed, A. / Amrizal, M. / Zafar, A. / De Rosas-Valera, M. / Encluna, J. / Rosminah, M. / Azmi, S. | 2013
The Potential Impact of Amnog-Triggered International Referenc Pricing: A Scenario from DPP-IV Inhibitors
Ando, G. / Van Mol, C. / Reinaud, F. / Honoré, A. C. | 2013
Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice
Giustina, A. / Bevan, J. / Bronstein, M. / Casanueva, F. / Chanson, P. / Petersenn, S. / Truong Thanh, X. M. / Massien, C. / Dias Barbosa, C. / Guillemin, I. | 2013
Generic Substitution in Ireland – The Views of Key Stakeholders
O’Leary, A. / Usher, C. / Lynch, M. | 2013
Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry
Charaan, M. | 2013
The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland
Carney, P. / Redmond, S. / Mahon, S. / Barry, C. | 2013
Exploring the Key Decision Drivers Provided by HTA Agencies Rejecting Submissions with ICERs Lower Than the Threshold
Walsh, S. C. / Goodrich, K. | 2013

Wie erhalte ich diesen Titel?

Feedback